<SEC-DOCUMENT>0001104659-24-050037.txt : 20240422
<SEC-HEADER>0001104659-24-050037.hdr.sgml : 20240422
<ACCEPTANCE-DATETIME>20240422163620
ACCESSION NUMBER:		0001104659-24-050037
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240422
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240422
DATE AS OF CHANGE:		20240422

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Theriva Biologics, Inc.
		CENTRAL INDEX KEY:			0000894158
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				133808303
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12584
		FILM NUMBER:		24861643

	BUSINESS ADDRESS:	
		STREET 1:		9605 MEDICAL CENTER DRIVE
		STREET 2:		SUITE 270
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		(734) 332-7800

	MAIL ADDRESS:	
		STREET 1:		9605 MEDICAL CENTER DRIVE
		STREET 2:		SUITE 270
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Synthetic Biologics, Inc.
		DATE OF NAME CHANGE:	20120305

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADEONA PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20081027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PIPEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20061214
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2412300d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:syn="http://syntheticbiologics.com/20240422">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_syn_syntheticbiologics.com_20240422 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20240422_20240422 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0000894158 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-04-22" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-04-22" id="Fact000004" name="dei:EntityCentralIndexKey">0000894158</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="syn-20240422.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-04-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000894158</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-22</xbrli:startDate>
        <xbrli:endDate>2024-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_907_edei--DocumentType_c20240422__20240422_zejUCqDFweBc"><ix:nonNumeric contextRef="AsOf2024-04-22" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event
reported): <span id="xdx_903_edei--DocumentPeriodEndDate_c20240422__20240422_ztJKdYiJJWv8"><ix:nonNumeric contextRef="AsOf2024-04-22" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">April 22, 2024</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90E_edei--EntityRegistrantName_c20240422__20240422_zRSg4enzoc82"><ix:nonNumeric contextRef="AsOf2024-04-22" id="Fact000011" name="dei:EntityRegistrantName">THERIVA BIOLOGICS, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 32%; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90D_edei--EntityIncorporationStateCountryCode_c20240422__20240422_zFNTCn7bFOPe"><ix:nonNumeric contextRef="AsOf2024-04-22" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="width: 1%; padding-right: 0.8pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 34%; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90B_edei--EntityFileNumber_c20240422__20240422_z2nszMy1MM8g"><ix:nonNumeric contextRef="AsOf2024-04-22" id="Fact000013" name="dei:EntityFileNumber">001-12584</ix:nonNumeric></span></b></span></td>
    <td style="width: 1%; padding-right: 0.8pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20240422__20240422_zb2A1129lCHi"><ix:nonNumeric contextRef="AsOf2024-04-22" id="Fact000014" name="dei:EntityTaxIdentificationNumber">13-3808303</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 0.8pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction of</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">incorporation)</p></td>
    <td style="padding-right: 0.8pt; text-align: center">&#160;</td>
    <td style="padding-right: 0.8pt; text-align: center"><span style="font-size: 10pt">(Commission File No.)</span></td>
    <td style="padding-right: 0.8pt; text-align: center">&#160;</td>
    <td style="padding-right: 0.8pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer Identification</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90D_edei--EntityAddressAddressLine1_c20240422__20240422_z0bFAQWIyVG7"><ix:nonNumeric contextRef="AsOf2024-04-22" id="Fact000015" name="dei:EntityAddressAddressLine1">9605 Medical Center Drive</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressAddressLine2_c20240422__20240422_zsP2XG0RhYPd"><ix:nonNumeric contextRef="AsOf2024-04-22" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 270</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_908_edei--EntityAddressCityOrTown_c20240422__20240422_zKtXfwoPBYhd"><ix:nonNumeric contextRef="AsOf2024-04-22" id="Fact000017" name="dei:EntityAddressCityOrTown">Rockville</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressStateOrProvince_c20240422__20240422_zT618xwkwqKg"><ix:nonNumeric contextRef="AsOf2024-04-22" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Maryland</ix:nonNumeric></span> <span id="xdx_90B_edei--EntityAddressPostalZipCode_c20240422__20240422_zZinyIR4trOj"><ix:nonNumeric contextRef="AsOf2024-04-22" id="Fact000019" name="dei:EntityAddressPostalZipCode">20850</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices and zip
code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_900_edei--CityAreaCode_c20240422__20240422_zosOWChGfZOe"><ix:nonNumeric contextRef="AsOf2024-04-22" id="Fact000020" name="dei:CityAreaCode">301</ix:nonNumeric></span>) <span id="xdx_909_edei--LocalPhoneNumber_c20240422__20240422_zd9wJZwYqXlc"><ix:nonNumeric contextRef="AsOf2024-04-22" id="Fact000021" name="dei:LocalPhoneNumber">417-4364</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_906_edei--WrittenCommunications_c20240422__20240422_zkc5EcaLiszl"><ix:nonNumeric contextRef="AsOf2024-04-22" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_907_edei--SolicitingMaterial_c20240422__20240422_zl6OtpljSpc1"><ix:nonNumeric contextRef="AsOf2024-04-22" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act
(17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_904_edei--PreCommencementTenderOffer_c20240422__20240422_zmunc8J3mNG5"><ix:nonNumeric contextRef="AsOf2024-04-22" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_902_edei--PreCommencementIssuerTenderOffer_c20240422__20240422_z3ZWB5tOM0hl"><ix:nonNumeric contextRef="AsOf2024-04-22" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border: black 1pt solid; width: 33%; padding-left: 6.4pt; text-align: center"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 34%; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 33%; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-left: 6.4pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_90D_edei--Security12bTitle_c20240422__20240422_zwtHIcfx77h7"><ix:nonNumeric contextRef="AsOf2024-04-22" id="Fact000026" name="dei:Security12bTitle">Common stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_900_edei--TradingSymbol_c20240422__20240422_zpNwgeMsxuEh"><ix:nonNumeric contextRef="AsOf2024-04-22" id="Fact000027" name="dei:TradingSymbol">TOVX</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_90D_edei--SecurityExchangeName_c20240422__20240422_zvI7u3xCLq4a"><ix:nonNumeric contextRef="AsOf2024-04-22" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">NYSE American</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company&#160;<span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_905_edei--EntityEmergingGrowthCompany_c20240422__20240422_zrhIKRG86O4h"><ix:nonNumeric contextRef="AsOf2024-04-22" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by checkmark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.&#160;<span style="font-family: Wingdings"><span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 7.01. Regulation FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On April 22, 2024, Theriva
Biologics, Inc. (the &#8220;Company&#8221;) issued a press release announcing the presentation of preclinical data demonstrating enhanced
anti-tumor effects in human pancreatic cancer xenograft-bearing mice treated with lead product candidate VCN-01 and liposomal irinotecan.
These data support the potential synergy of VCN-01 and first-line pancreatic cancer chemotherapy regimens, and will be featured in a poster
presentation at the American Society for Cell and Gene Therapy (the &#8220;ASGCT&#8221;)) 27<sup>th</sup> Annual Meeting on May 10, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Key takeaways include: </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Overview: The combination of VCN-01 + topoisomerase I (topo1) inhibitors,
such as liposomal irinotecan, has a tolerable toxicity profile and may improve the efficacy in the treatment of human pancreatic cancer.</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="font-family: Times New Roman, Times, Serif">In vitro: Viral protein expression was increased in human pancreatic cancer
cell lines when they were exposed to topo1 inhibiting chemotherapeutics, irinotecan, its active metabolite, SN-38, and topotecan.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="font-family: Times New Roman, Times, Serif">In vivo: Synergy of VCN-01 plus liposomal irinotecan was observed in animals
bearing subcutaneous human pancreatic tumors. </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">o</td><td>In human pancreatic mouse xenograft models, treatment with VCN-01 at a dose of 4x10<sup>10</sup> vp or liposomal irinotecan alone
(at both the 10 mg/kg and 5 mg/kg doses) resulted in significant tumor growth inhibition compared to saline.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">o</td><td>Combination therapy with VCN-01 + liposomal irinotecan at either dose displayed significantly reduced tumor growth compared to each
treatment alone.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">o</td><td>qPCR analyses performed on tumors collected at end of study confirmed the presence of viral genomes, indicating ongoing transcriptional
activity of VCN-01, which is consistent with viral replication for several days after administration.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white">The full abstract for the poster
presentation has been&#160;released by the ASGCT. </span>A copy of the abstract titled &#8220;Enhanced Anti-Tumor Efficacy of Combination
Therapy with the Oncolytic Adenovirus, VCN-01, and Liposomal Irinotecan in a Human Pancreatic Mouse Xenograft&#8221; is filed as an exhibit
to this Current Report on Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The information in this
Item 7.01 and in the press release furnished as Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed to be &#8220;filed&#8221;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section
or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended and shall not be incorporated by reference into any filing with
the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general
incorporation language in such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The press release furnished
as Exhibit 99. to this Current Report on Form 8-K includes &#8220;safe harbor&#8221; language pursuant to the Private Securities Litigation
Reform Act of 1995, as amended, indicating that certain statements contained therein are &#8220;forward-looking&#8221; rather than historical.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 8.01. Other Events.</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 22, 2024, the Company issued a press
release announcing the presentation of preclinical data demonstrating enhanced anti-tumor effects in a human pancreatic mouse xenograft
treated with lead product candidate, VCN-01 and liposomal irinotecan. These data support the potential synergy of VCN-01 and first-line
pancreatic cancer chemotherapy regimens</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Key takeaways include: </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Overview: The combination of VCN-01 + topo1 inhibitors, such as liposomal
irinotecan, has a tolerable toxicity profile and may improve the efficacy in the treatment of human pancreatic cancer.</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="font-family: Times New Roman, Times, Serif">In vitro: Viral protein expression was increased in human pancreatic cancer
cell lines when they were exposed to topoisomerase I (topo1) inhibiting chemotherapeutics, irinotecan, its active metabolite, SN-38, and
topotecan.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="font-family: Times New Roman, Times, Serif">In vivo: Synergy of VCN-01 plus liposomal irinotecan was observed in animals
bearing subcutaneous human pancreatic tumors. </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">o</td><td>In human pancreatic mouse xenograft models, treatment with VCN-01 at a dose of 4x10<sup>10</sup> vp or liposomal irinotecan alone
(at both the 10 mg/kg and 5 mg/kg doses) resulted in significant tumor growth inhibition compared to saline.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">o</td><td>Combination therapy with VCN-01 + liposomal irinotecan at either dose displayed significantly reduced tumor growth compared to each
treatment alone.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">o</td><td>qPCR analyses performed on tumors collected at end of study confirmed the presence of viral genomes, indicating ongoing transcriptional
activity of VCN-01, which is consistent with viral replication for several days after administration.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"/><td/></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white">The full abstract for the poster
presentation has been&#160;released by the ASGCT. The poster will be presented at the ASGCT </span>27<sup>th</sup> Annual Meeting on May
10, 2024</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"></span></td><td/></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 26.2pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%; padding-right: 0.8pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">(d)&#160;&#160;</span></td>
    <td style="width: 96%; padding-right: 0.8pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">Exhibits.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 0.8pt; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Exhibit<br/>
Number</b></span></td>
    <td style="vertical-align: top; width: 3%; padding-right: 0.8pt; font-size: 10pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 87%; padding-right: 0.8pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b>Description</b></span></td></tr>
  <tr>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><a href="tm2412300d1_ex99-1.htm">99.1</a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0; text-align: center"><a href="tm2412300d1_ex99-2.htm">99.2</a></p></td>
    <td style="vertical-align: bottom; padding-right: 0.8pt; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><a href="tm2412300d1_ex99-1.htm">Press Release issued by Theriva Biologics, Inc., dated April 22, 2024</a></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><a href="tm2412300d1_ex99-2.htm">Abstract titled &#8220;Enhanced Anti-Tumor Efficacy of Combination Therapy with the Oncolytic Adenovirus, VCN-01, and Liposomal Irinotecan in a Human Pancreatic Mouse Xenograft</a></span>.&#8221;</p></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 0.8pt; text-align: center; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">104</span></td>
    <td style="vertical-align: bottom; padding-right: 0.8pt; font-size: 10pt">&#160;</td>
    <td style="vertical-align: top; padding-right: 0.8pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif">Cover Page Interactive Data File (embedded within the XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 26.2pt">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td>Dated: April 22, 2024</td>
  <td colspan="3"><b>&#160;THERIVA BIOLOGICS, INC.</b></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="width: 50%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
    <td style="width: 40%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="padding-bottom: 1pt">&#160;</td>
  <td>By:</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">/s/ Steven A. Shallcross</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>Name:</td>
    <td>Steven A. Shallcross</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>Title:</td>
    <td>Chief Executive Officer and Chief Financial Officer</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2412300d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: left"><B><IMG SRC="tm2412300d1_ex99-1img001.jpg" ALT="">&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Theriva&trade; Biologics to Present Preclinical
Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell
and Gene Therapy 27<SUP>th</SUP> Annual Meeting </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&ndash; <FONT STYLE="font-size: 10pt">Lead
product candidate, VCN-01 in combination with liposomal irinotecan demonstrated enhanced anti-tumor effects in a human pancreatic mouse
xenograft</FONT>&ndash;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&ndash; The observed synergy emphasizes VCN-01&rsquo;s
potential in diverse chemotherapy combinations for improved efficacy in the treatment of pancreatic cancer&ndash;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Rockville, MD, April 22, 2024 &ndash;</B> Theriva&trade; Biologics
(NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in
areas of high unmet need, today announced the presentation of preclinical data demonstrating enhanced anti-tumor effects in human pancreatic
cancer xenograft-bearing mice treated with lead product candidate VCN-01 and liposomal irinotecan. These data support the potential synergy
of VCN-01 and first-line pancreatic cancer chemotherapy regimens, and will be featured in a poster presentation at the American Society
for Cell and Gene Therapy (ASGCT) 27<SUP>th</SUP> Annual Meeting, being held both virtually and in Baltimore from May 7-11, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;The data featured at the upcoming ASGCT meeting build on recent
findings that suggest the combination of VCN-01 and topoisomerase I inhibitors, such as liposomal irinotecan, may provide a synergistic
antitumor effect to improve therapeutic outcomes across indications,&rdquo; said Steven A. Shallcross, Chief Executive Officer of Theriva
Biologics. &ldquo;We look forward to leveraging these findings and evaluating the combination of VCN-01 with additional first-line pancreatic
cancer chemotherapy regimens, including NALIRIFOX and FOLFIRINOX. In parallel, we continue to progress our on-going VIRAGE Phase 2b trial
evaluating VCN-01 in combination with gemcitabine/nab-paclitaxel to treat metastatic pancreatic ductal adenocarcinoma (PDAC). Together,
these important steps bring us one step closer to building a portfolio of potentially improved therapeutic combinations for PDAC patients
with high unmet medical needs.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Key takeaways include:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Overview: The combination of VCN-01 + topoisomerase I (topo1) inhibitors,
such as liposomal irinotecan, has a tolerable toxicity profile and may improve efficacy in the treatment of human pancreatic cancer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>In vitro: Viral protein
                                            expression was increased in human pancreatic cancer cell lines when they were exposed to
                                            topo1 inhibiting chemotherapeutics, irinotecan, its active metabolite, SN-38, and topotecan.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>In vivo: Synergy of
                                            VCN-01 plus liposomal irinotecan was observed in animals bearing subcutaneous human pancreatic
                                            tumors.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>In
                                            human pancreatic mouse xenograft models, treatment with VCN-01 at a dose of 4x10<SUP>10</SUP>
                                            vp or liposomal irinotecan alone (at both the 10 mg/kg and 5 mg/kg doses) resulted in significant
                                            tumor growth inhibition compared to saline.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>Combination
                                            therapy with VCN-01 + liposomal irinotecan at either dose displayed significantly reduced
                                            tumor growth compared to each treatment alone.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt "><IMG SRC="tm2412300d1_ex99-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>qPCR
                                            analyses performed on tumors collected at end of study confirmed the presence of viral genomes,
                                            indicating ongoing transcriptional activity of VCN-01, which is consistent with viral replication
                                            for several days after administration.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The full abstract (1760) for the poster presentation is accessible
on the ASGCT Congress portal and the poster will be available starting, Friday, May 10, 2024. Additional details on the poster are provided
below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left"><B>Title:
                                            </B>Enhanced Anti-Tumor Efficacy of Combination Therapy with the Oncolytic Adenovirus, VCN-01,
                                            and Liposomal Irinotecan in a Human Pancreatic Mouse Xenograft</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Session
                                            Title:</B> Cancer - Oncolytic Viruses</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Presenting
                                            Author:</B> Dr. Sheila Connelly, Vice President of Research, Theriva Biologics, Inc.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Poster
                                            Session Date and Time:</B> Friday, May 10, 2024 at 12:00 p.m. ET</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Theriva&trade; Biologics, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Theriva&trade; Biologics (NYSE American: TOVX), is a diversified clinical-stage
company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need. The Company is advancing a
new oncolytic adenovirus platform designed for intravenous (IV), intravitreal and antitumoral delivery to trigger tumor cell death, improve
access of co-administered cancer therapies to the tumor, and promote a robust and sustained anti-tumor response by the patient&rsquo;s
immune system. The Company&rsquo;s lead candidates are: (1) VCN-01, an oncolytic adenovirus designed to replicate selectively and aggressively
within tumor cells, and to degrade the tumor stroma barrier that serves as a significant physical and immunosuppressive barrier to cancer
treatment; (2) SYN-004 (ribaxamase) which is designed to degrade certain commonly used IV beta-lactam antibiotics within the gastrointestinal
(GI) tract to prevent microbiome damage, thereby limiting overgrowth of pathogenic organisms such as VRE (vancomycin resistant Enterococci)
and reducing the incidence and severity of acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant (HCT)
recipients; and (3) SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase (IAP) produced under cGMP conditions
and intended to treat both local GI and systemic diseases. For more information, please visit Theriva Biologics&rsquo; website at <U>www.therivabio.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2412300d1_ex99-1img001.jpg" ALT=""></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">This release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified
by terminology such as &ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue,&rdquo; &ldquo;expects,&rdquo;
&ldquo;anticipates,&rdquo; &ldquo;intends,&rdquo; &ldquo;plans,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; and similar expressions,
and include statements regarding the potential synergy between lead product candidate, VCN-01 and first-line pancreatic cancer chemotherapy
regimens; the suggestion that the combination of VCN-01 and topoisomerase I inhibitors, such as liposomal irinotecan, may provide a synergistic
antitumor effect to improve therapeutic outcomes across indications; leveraging these findings and evaluating the combination of VCN-01
with the additional first-line pancreatic cancer chemotherapy regimens, including NALIRIFOX and FOLFIRINOX; and continuing to progress
our on-going VIRAGE Phase 2b trial evaluating VCN-01 in combination with gemcitabine/nab-paclitaxel to treat metastatic pancreatic ductal
adenocarcinoma (PDAC). Important factors that could cause actual results to differ materially from current expectations include, among
others, the ability to generate clinical data that establishes a synergy between lead product candidate, VCN-01 and first-line pancreatic
cancer chemotherapy regimen and provides an antitumor effect; the Company&rsquo;s and VCN&rsquo;s product candidates demonstrating safety
and effectiveness, as well as results that are consistent with prior results; the ability to complete clinical trials on time and achieve
the desired results and benefits; the ability to obtain regulatory approval for commercialization of product candidates or to comply
with ongoing regulatory requirements, regulatory limitations relating to the Company&rsquo;s and VCN&rsquo;s ability to promote or commercialize
their product candidates for the specific indications, acceptance of product candidates in the marketplace and the successful development,
marketing or sale of the Company&rsquo;s and VCN&rsquo;s products, developments by competitors that render such products obsolete or
non-competitive, the Company&rsquo;s and VCN&rsquo;s ability to maintain license agreements, the continued maintenance and growth of
the Company&rsquo;s and VCN&rsquo;s patent estate, the ability to continue to remain well financed, and other factors described in the
Company&rsquo;s Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2023 and its other filings with the SEC, including
subsequent periodic reports on Forms 10-Q and current reports on Form&nbsp;8-K. The information in this release is provided only as of
the date of this release, and Theriva Biologics undertakes no obligation to update any forward-looking statements contained in this release
on account of new information, future events, or otherwise, except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>For further information, please contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chris Calabrese<BR>
LifeSci Advisors, LLC<BR>
ccalabrese@lifesciadvisors.com<BR>
917-680-5608</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Source: Theriva Biologics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>tm2412300d1_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.2</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2024 ASGCT Abstract, version 4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Section F2: Cancer: Oncolytic Viruses</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Title:</B> Enhanced Anti-Tumor Efficacy of
Combination Therapy with the Oncolytic Adenovirus, VCN-01, and Liposomal Irinotecan in Human Pancreatic Mouse Xenografts</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Authors</B>: Maria V. Maliandi<SUP>1</SUP>,
Paz Moreno<SUP>1</SUP>, Ramon Alemany<SUP>1,2</SUP>, Manel Cascallo<SUP>1</SUP>, Sheila Connelly<SUP>3</SUP>, Ana Mato-Berciano<SUP>1</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Affiliations</B>: <SUP>1</SUP>Theriva Biologics,
S.L., Barcelona, Spain, <SUP>2</SUP>Catalan Institute of Oncology (ICO), L&rsquo;Hospitalet de Llobregat, Barcelona, Spain, <SUP>3</SUP>Theriva
Biologics, Inc., Rockville, MD, USA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">VCN-01 is a clinical-stage oncolytic adenovirus
engineered to replicate selectively in cancer cells with an aberrant RB1-E2F pathway. The VCN-01 E1A promoter is modified by inclusion
of eight E2F1 binding sites and a 24-bp deletion that promotes viral transcription in cells with elevated free E2F1 and renders the virus
replication-deficient in RB1-functional, normal cells. Here, human pancreatic cancer cell lines were exposed to topoisomerase I (topo1)
inhibiting chemotherapeutics, irinotecan (IRI), its active metabolite, SN-38, and topotecan (topo; see Figure A). Notably, in NP-18 cells,
E2F1 mRNA was increased ~3-fold compared to untreated cells, and E1A mRNA was boosted ~5-fold in cells treated with VCN-01 + topo1 inhibitors
compared to VCN-01 alone. These data suggest topo1 inhibitor-mediated elevations in E2F1 increase VCN-01 transcription. Based on these
promising in vitro results, potential synergy of VCN-01 plus the liposomal formulation of IRI (nal-IRI) was tested in animals bearing
subcutaneous human pancreatic tumors . After tumors were established, indicated animals were treated with a single IV dose of VCN-01 (4x10<SUP>10</SUP>
vp) or PBS (day 1). Designated animals in each group were then treated with either PBS or nal-IRI (IP) on days 3, 10 and 17. In animals
with NP-18 tumors, treatment with VCN-01 or Nal-IRI alone at both the 10 mg/kg and 5 mg/kg doses resulted in significant tumor growth
inhibition compared to PBS (see Figure B). Importantly, combination therapy with VCN-01 + nal-IRI at either dose displayed significantly
reduced tumor growth compared to each treatment alone. qPCR analyses performed on tumors collected at end of study confirmed the presence
of viral genomes and E1A mRNA suggesting intratumoral viral replication and indicating ongoing transcriptional activity of VCN-01. Preliminary
analyses suggest that combination therapy with VCN-01 + nal-IRI has a tolerable toxicity profile. These data are consistent with the hypothesis
that topo1 inhibitors increase cellular E2F1 protein expression resulting in upregulation of the modified VCN-01 E1A promoter thereby
enhancing viral gene expression and improving anti-tumor efficacy. The combination of VCN-01 + topo1 inhibitors, such as Nal-IRI, may
demonstrate improved efficacy in the treatment of human pancreatic cancer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[See Figure below]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="image_005.jpg" ALT="" STYLE="height: 317.5pt; width: 468pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *8 ](# 2(  A$! Q$!_\0
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M_P"$3\.?]"_I7_@''_A0!G_\+(\%?]#1I7_@2M'_  LCP5_T-&E?^!*UH?\
M")^'/^A?TK_P#C_PH_X1/PY_T+^E?^ <?^% &?\ \+(\%?\ 0T:5_P"!*T?\
M+(\%?]#1I7_@2M:'_")^'/\ H7]*_P# ./\ PH_X1/PY_P!"_I7_ (!Q_P"%
M &?_ ,+(\%?]#1I7_@2M'_"R/!7_ $-&E?\ @2M:'_")^'/^A?TK_P  X_\
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M_P"% &?_ ,+(\%?]#1I7_@2M'_"R/!7_ $-&E?\ @2M:'_")^'/^A?TK_P
MX_\ "C_A$_#G_0OZ5_X!Q_X4 9__  LCP5_T-&E?^!*T?\+(\%?]#1I7_@2M
M:'_")^'/^A?TK_P#C_PH_P"$3\.?]"_I7_@''_A0!G_\+(\%?]#1I7_@2M'_
M  LCP5_T-&E?^!*UH?\ ")^'/^A?TK_P#C_PH_X1/PY_T+^E?^ <?^% &?\
M\+(\%?\ 0T:5_P"!*T?\+(\%?]#1I7_@2M:'_")^'/\ H7]*_P# ./\ PH_X
M1/PY_P!"_I7_ (!Q_P"% &?_ ,+(\%?]#1I7_@2M'_"R/!7_ $-&E?\ @2M:
M'_")^'/^A?TK_P  X_\ "C_A$_#G_0OZ5_X!Q_X4 9__  LCP5_T-&E?^!*T
M?\+(\%?]#1I7_@2M:'_")^'/^A?TK_P#C_PH_P"$3\.?]"_I7_@''_A0!G_\
M+(\%?]#1I7_@2M'_  LCP5_T-&E?^!*UH?\ ")^'/^A?TK_P#C_PH_X1/PY_
MT+^E?^ <?^% &?\ \+(\%?\ 0T:5_P"!*T?\+(\%?]#1I7_@2M:'_")^'/\
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M2M'_  LCP5_T-&E?^!*UH?\ ")^'/^A?TK_P#C_PH_X1/PY_T+^E?^ <?^%
M&?\ \+(\%?\ 0T:5_P"!*T?\+(\%?]#1I7_@2M:'_")^'/\ H7]*_P# ./\
MPH_X1/PY_P!"_I7_ (!Q_P"% &?_ ,+(\%?]#1I7_@2M'_"R/!7_ $-&E?\
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M-&E?^!*UH?\ ")^'/^A?TK_P#C_PH_X1/PY_T+^E?^ <?^% &?\ \+(\%?\
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M?^% &?\ \+(\%?\ 0T:5_P"!*T?\+(\%?]#1I7_@2M:'_")^'/\ H7]*_P#
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MH **** "O/[[_DO6E?\ 8!F_]&UZ!7G]]_R7K2O^P#-_Z-H ] HHHH *\_\
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MJ]*\$?#_ $?P)820::'DGF(,US+C>^.@]A[4 =71110 4444 %%%% !1110
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>?WW_ "7K2O\
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y_??\EZTK_L S?^C:]
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MQ-%8ZQXBM8V.YD@U#8"?4@+UKJE\(::OBNW\1[[DW\%K]D7=)E2GJ1CD^^:
M,?PWX7\2MH6J:9XUUN/5DO!L4P#:40C##.T=:Y70M(L-#^/\FGZ9:QVUK#HH
M"1H/]WD^I]S7L-8*>$M.3QE)XJ#3_P!HO;?9B-_[O9Q_#CKQZT ;U%%% !11
M10 4444 %%%% !1110 445E:OXET30/+_M;5;2R\S[@GE"EOIF@#5HJ&UN[>
M]MH[FUFCG@D&Y)(V#*P]B*FH **** "BBB@ HHHH ^5EMOAY/XG\2-XQOM0M
M[L:E*(5M02I3/?"GG.:]J^%W_"'S>&)K/PK-/=Z?;W.7-W&=PD.#W4>W:NJE
M\,:!/*\LVAZ9)(YRSO:1DL?4DCFK5EIECID;1V%E;6B.=S+;Q+&"?4@ <T >
M:> I$3XM?$)G8!5DB+$GH.:X6V7QSXRU;Q/KOA[2["[T[5F:Q+W3*"(EX 7+
M#VY]17T,FFV44UQ-'9VZ2W'$[K$H:7_>..?QIUK96UA (+.VAMH021'#&$4$
M]>!Q0!Y[\%]8FNO![Z)?#9J&BS-:2H3D@#[O^'X5Z55:#3[.UN)KBWM+>&><
MYEDCB"M(?]H@9/XU9H **** "BBB@ HHHH ***J:AJEAI-JUSJ-Y!:P*,F2:
M0*!^= %NJU^;D6,YLE1KH(?*#_=W=LUSB_$[P0\IC'B;3LCN9@!^?2M?4=9A
MM= N=5M,7JQ1&2-8&W>8<9 !'K0!Q,.O^(?#_C'0M(UF^M[V35@PDAC&/((Y
MR/:JFC>*;[Q#XGU2V?Q&EA';WIM[: (#Y@!]:Q?AX1JOBV7Q1XE2[.LW+-'9
MV[PL$@3ZT_Q2]CK.E3:!HWARYL-:.HJ580D!2&YEW^E &]K7BO7+S7=<L]$G
MCBCT&W$LNX9,[XR5/H,4Z;QOJ6NMX=TW272TN]5M3<32D9\K Y _&L+4([KP
MGXE\4"ZLKJX.M6*I;RP1EP\NW:0<=*6/2;SP=?\ @W5[VTGFM[:R:"Y\A"QB
M<\C@4 =YX"\17FOZ5=)J2*M]87+6LS+T<K_%^-=7QZBO// .C7=YX:UR2Z\^
MR&KW<LL)'RR(AZ-[&LO7/AM-I7A^^OX?%>LF6WA:1=TW!(% 'J_I2BN5^'%U
M<7W@+2KBZE:69XLL['DUU8XH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBD)H 6BDS1F@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\_OO\
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M3U&J6+S^';T6L=H$ND4G$L@/?UKUJP=9+&%T@,"%1B(C!7VH M4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4449H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KS^^_Y+UI7_8!F_\ 1M>@5Y_??\EZTK_L
M S?^C: /0**** "O/_'/_)0OA_\ ]?MS_P"BJ] KS_QS_P E"^'_ /U^W/\
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M*** "BBB@ HHI,T +6+XN_Y$W6O^O*;_ - -;.:QO%W_ ")NM?\ 7E-_Z :
M,GX6?\DO\/\ _7HO\S785Q_PL_Y)?X?_ .O1?YFNPH **** "BBB@ HHHH *
M*** $J&#[TO^^:GJ"W^]+_OFI>Z&MF3T4450A,TN:CE\WRR80I?L&.!5#[3J
M)NS;^3;;@F_.]L8SCTH(E/EW-/-%1Q>88QYH4/W"G(J2@H*X'XP&-? C'[(U
MS<_;(!:J#PLV_P"4MVV]CGUKOJ\V^).K>'M5AF\(ZIXA?0IV*3&>2$^7(O7
M8X4\^_44#*,>I?&-8D5O#&B,P&"?M"#/X;N*])N;:>^TEX'D:VN)H=K/&>48
MCG!]J\67P[9VEFI'QJF2 #@F52,?4R5Z+9>,+/Q!IFI67A:].H7]E;A1<>61
M&SD8!#'ACD9XH XTRIX;^)FA:+H^I75Y,L+G4_,DWC;@D%O0UCP7NHW7A>;Q
MDFIW2WZ:WY84R?)Y(?&S'I71?#GPGK'AVXN)M6TSS]1U!V^U7K-DJI["H$\
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MMPL3W$1CB4]7;(X%:?@W7=.U_P ,V5SIMPLT:1+&^.JL ,@T ;#7UHK%6NH
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MRFOI;&*ZB>ZB&9(58%E'N*SKGQAX=L[TV5QK-G'<AMIB:0;@?3% &W16;?\
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MT*Y+P1JMUJ$6H123_:[2UG\JUO/^>ZXZY[X/%=<* "BBB@ HHHH *8ZAU*L
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M$#UKP2+P[X M;J:Y@^*=[%<3'][+'.0TG^\1R?QKW3PPEM'X8TU+34)-1MQ
MHCO)&W-,/[Q/?- &Q111F@ K%\7?\B;K7_7E-_Z :VJQ?%W_ ")NM?\ 7E-_
MZ : ,GX6?\DO\/\ _7HO\S785Q_PL_Y)?X?_ .O1?YFNPH **** "C-)5'5=
M5ATFU$\X8J6"_+ZTXQ<G9;DRDHJ[+<W^HD_W3_*HK#_CP@_W!7/2>-]-:-E\
MN;)!'04RV\:Z;#;1QLDV57!X%=7U2O;X68?6:5_B.LJO??\ 'E+]*IZ1KUMK
M#RK;JX\L G</6KE]_P >4OTKBKPE",HR5G8ZJ,E)IQV(-'_Y!R_[Q_G5^J&C
M_P#(.7_>/\ZOUE0_A1]#2M_$EZF0G_(P2?0?RK8K'3_D8)/H/Y5KGI48?[7J
MRJ_V?1'&7/CSR+R>W33993$VTE#FJG_"<2?;3<?V3<?ZO9C!]<^E7?!PSK&N
MY_Y[UV&T>@KJ1\]0AB<1!5'5MJ^B[G%P>/?,NX8'TV:/S7" L<=3BNUS7&^-
M@!J.A<?\O/\ 45V7:@ZL)*ISSIU)7Y;=+;JXM8OB9/$#Z1CPS+9QZAYB_-=J
M2FSG/3OTK:KS'XF>+O"ZK)X:U/7]2TF\1XYFEL89"P&,@;E'0YH/0,SQ#JOQ
M;\-Z2^IW=SX?>TB9?.>.)OW:D@;B">1DCI7J,ZW5YH;I;W"QW<MO\DRC@,1]
MX>V:^=?-^'D[JFI>//$]_:;@SVTT<Q5\'.#D&OI.V,;6D)@&(3&I08_AQQ^E
M 'C_ ,-])?0_BQXELI;N2\N$MHVDGDZNQY-5HDU?P-=:IX@US0=/FTN[U/,K
MRJ&G16. PSVKT+3/!TFG^/=8\2&]#IJ,2QB +@I@=<UE7WP^U?59&L-2\0M=
M:"UR+@V\B9E.#D)N_NT <N8[?Q#XH\?/>Q+,EM8@6K.,^6NS<"OH:@T.X;7=
M?\#66I 7-L--=FCD^978<9(/6NTUWX?75WJ=U=:+J:6$5_;BVO8FCW;T''R^
MAQ4^I^ 3Y.CR:%?"QO\ 28O)@FD3<&3'(8=Z ,KX=WT>BZ#XF,I=K+3M0FV*
MHW;4'\(']*S_ !%\7O#U_P"&M2MH8-0$DUNR*6MV R1WKN_"7AB/PSI$EJTW
MVB>XE:>YE(P'=NO'I2^+X(5\'ZPPAC!%I)T4>E 'GW@#5M2U#1+/1-/DMK0:
M?;HSS3CYG+C(V>WK7;>'-<OIM>O]"U(Q33VL2RK<0?=96/0_[58'@?P]INK?
M#W1KJXA_TI+?Y9$.UR/3-==X9TVVL-,$D-C]DGG.^96.7)]2: ->::.WB>:5
M@D:*69CT %<C'X]T&1/*778C-<N5@;RS\O/&>./QK>\0Z;)JVAW5E$^R21?E
M/N.<5S=YX4:70KN2WTR"+5=1AC@GY&U O&X4 =I!O$";W#M@98=#4M5[& VE
MA;V[/O:*-4+>N!5B@ HHHH *\_U6T\1:AXKNK9M/TE[14#VUQ-'EF'=2?:N_
M/2LG6M:71$AEFM)YH78AVA3<4_"@!- M=2M+)HM02SC*M^[6T7:H7Z5KKTK/
MT[6].U=";&\BE91\R!AN3V([5H"@!:*** "BBB@ IO>G52U6].G:7=W@3>8(
MC(%]<"@#SOQEHFMW>LWMQ'!?30I'NA%H^T.",;3ZG/-=SX8ANK?PSI\5\K+<
MK"HD#')!]_>N,CO#<Z6=9?QA''>^69A L@$2\9"E?TKM?#FIOK'AZROY-N^:
M(,Q7H3ZB@#6HHHH **** "BBB@ HHHH *,TUB0I(&3C@>M<'_P )7XI_X2C^
MQ?[!A#%/.#^>,>7NQGZT =[]:X76-+TZ3XBZ.7T^T;?'(6)A4ECCJ>*[D9P"
M1R>M>?ZYK^DVWQ0T>VFOX4F6-U92X^4D< ^AH []55 %50J@8  X KB_&UY:
MVFM:#)<W$<2I.6)9@,"M;4_&6C:8WE?:#=7 ./(M1YCCZ@=*^:OBG;>*=3\:
M&YO["Z1;G'V*,9/R=@/>@#Z*\/V\NM:M-XDNT*H<Q6,3C[D?][ZG^5=5Q6!X
M'M]3M?!FE0:P<WZ0 29[>@_*N@(H SK[1-,U.59;VRAG=1@&10<58M+.UT^
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M9#)!'(R["Z@D>AKG]5T"SN;]99;2S=I3RTD(8_G71@ * .U8VHZC;1WD2/*
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MI_UV7^1KSNO1/'/_ " T_P"NR_R->=U]-E?\#YG@X_\ B@*]8\/_ /(OV/\
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MO4(+CP//!$]NX>1IP0@QUZ5Z9H>A6/AW34T_3H]D*DL23DLQZDGN:K>,,_\
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M2]6;H*+@?/\ \)/A/(=:GU76UBD@LY&B2'.0[CC/TKZ"B@A@01PQ)&H& %4
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MKW>DQ0!X)_PKSXBWT/AG3M132AI^ASQO$8I,.5!7.3WX'M7OE)BEH ***,T
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M8R <5X=XB\(7OB;X]7<:W6HZ;;'3T87MIE<D*OR[OZ>U>YTE!V'EG_"F9O\
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MPJ*, "LGQA_R)NL?]>DG\J ,OX78/PYT?'3R1785Q_PM_P"2<Z/_ -<:["@
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M_8!F_P#1M>@5Y_??\EZTK_L S?\ HV@#T"BBB@ KS_QS_P E"^'_ /U^W/\
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M%:6^=H>1L9/H!W->6_$S7M)U>#PMJQF&I>$%OB-0^SMN7./EW@<\'/'UK/\
M%FI)9^/-*\2Z]<1Z[X'N"WV1D0216LC #E1UZ=^N3W%7/ -CIU]\1-??P]:&
M3P;=VRF9)82('GX.$5AR.O\ G% $.AIH2?&C3I? 3H^GS6;'5%M23 HYV^P;
M..*]NJCIFC:;HUN8-,L;>TB/)6&,+D^^.OXU>H **** "BBB@ HHHH ****
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MEKG@GQ9?:;9.L_A&X4SP^9)\]M(3]P#O_+IWKT>DQ2T %%%% !1110 4444
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M ",FM_\ @0:Z.[\*I=^.+'Q(;EE>UMV@$0'!R<YKHQ0!YS_PJ*W_ .ADUO\
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M<W$?B/6M\<;.N;@]A7J%5[RW%W93VY;:)4*9],B@#C?A)<W-U\/[22ZN))Y
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M/[3LR)6CMSAI%'\.>HSV/J,5A_$G6K#7#X&N[QG/A2_N/-N>2 Q(&P/CL/\
M&NXUJ32/A_X2U37M(TBT7RXED*0 1B7D!>1]: /'-+UCQUXP\(7EC>V=GXEM
M4+1W5HY$5Y;./ND=.1V(!]/6NB^$,]WJ>IKIGBCP[.^HZ)&19:A=0'="A/\
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M)=EOE1"V6#>] 'K>G77VW3;:ZQM,T:N1Z$BK=5K&U%G8V]LI)$4:IGUP*LT
M%%%% !1110 4444 <GXUTJXOK);H:G>VEK:*TDD-G]^4@<"O.X_%VM+\+-)\
MS4G:\U'41:"X!_>Q1EL8;_:Q7IWB'4];TRZMY-/TI;ZS8$3;6_>*>V!W%>?/
M\.]8D\'O,T<8U7^UAJB6P.%49^Y]<4 ;_@^>_P!)\<:MX8GOKB]LXHDG@EN&
MW.N1R,_6O1*X3PGI6JW/B_5/$^IVYM$N(DA@MV^\H'4G\:[N@ HHHH ****
M"BBB@!"P ))  Y.:\<E\9:GK7QCTVTM)I(]#1GA7'29U^\?>O6K^T^W6%Q:>
M8T?G(4+KU&1VKR:X^&^L:;XK\.#3M1F>PL]^Z8QC,>?7USZT 0ZMJ6L:R?%N
MMVVKW=L=$G"VMO$V$95Y.X=\UZOH5^VJ>']/U"10KW%NDK#T) ->9:GX8\0Z
M<_B31].LA/;Z[*KQW6>(P>&W>E>H:-I_]EZ)8V&[=]FA6+/K@8H OT444 %%
M%% !1110 4444 %%%% !1110 5Y_??\ )>M*_P"P#-_Z-KT"O/[[_DO6E?\
M8!F_]&T >@4444 %>?\ CG_DH7P__P"OVY_]%5Z!7G_CG_DH7P__ .OVY_\
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MJCT J>BB@ HHHH **** "BBB@!,48I:* "BBB@ HHHH **** "BBB@ HHHH
M\O\ $7C#QIX+\07%[JFCQ:CX7=ALDL0?,MU_VL]3]<#WKG?"_B31$^,,L^CW
M<4^D>*(,O'CF.X&<JZGH3SQ[BO<&0,I5@"I&"#T(KAY_A'X4E\56OB"*S>VN
M()/-,5N^R-W!R"0.G/IB@"A=?!3PW-J%Q/;76IV-M='-Q9VMSLBD]L8Z>U=W
MI6E6.B:;!IVFVR6]I NU(T' _P 3[U:GGBMH))YG6.*-2[NQX50,DFN TKXM
MZ9JNO6=BNE:E!97\C166HRQXBG8>G>@#K];MI=5TN\TRRU0V%Y)'Q-$ SQ ]
M\'\LUY'=Z_XH\):9/HGCVT.L>'KN,P#6+0;V12, L.^.O.#QWJK\3].\2WOC
M'4[_ ,+Z9J-H;6Q$>HWD<FT749P<(.Y ].>*]4\%V.G1^!-+M;6VN/L+VX(A
MOAN?!Y(8'^72@#A_@OJ=AXC\#WOAJ]\J^BT^9H@LJY$D#'*'!_$?A7=:'X!\
M+>&[QKS2-%M[:X88\T99@/8L3C\*NZ)X8T3PX;C^Q]-@L_M+[Y3$N-Q_P]NE
M4?%'C?2O"-[I=OJ@G1-0E,2SA/W<9]6;MV_G0!O7331VLKV\0EF5"8XRVT,V
M.!GMSWKRRW^)T<DUUX7^(6DMHEQ<H\(E.3!(K C[W;Z]*=\4_'-_X/UK1KO2
M=0BN6:-_.TC;GS4(R)=PY&,?I]:U_"-F?'G@&*?Q:^GZN+UVF18D %NI_@!'
M(8=/\: .9^'6F6&N^&->^'FNA;E-,N3Y3*V?W;$E'5O8YQ6G;?!@F.#3]4\5
MZGJ&AV\F^/3G&U3CH&;.2!Z?RK3\&?"?3O!/B2[U:QU&\ECFB\J.VD(Q&O!Y
M/\73CIBO0: &10I!"D42A(XU"JJ] !VK!\6:?JNLZ%/::#K:Z7?(P;S@H;&.
M=I_N@U?U#Q#HVDSQP:CJEI:RR_<2:95+?0&OGWQ7%K,OB/7M4TNUUNP\)W%Y
M'%JK1'+S$'#.BGG'N/4?2@#7\4^*M5;PO?>$OB+IAM;B2/-GJT*;H9)%Y4G'
M0GID>IX%=+X8TC0?BS\.M)N-:A,E]9K]G:XA?;*C+QU]#P<'UKT,:/IE_P"'
MH=-N;875@8541W0W$KCC.><X[]:- \.:5X8TT:?H]FEK;ABQ5>2Q/<D\DT 9
MOA7P#H/@_P U],MW:ZFXENKA_,E<>A;T^E=/110 4444 %%%% !1110 4444
M %%%% !1110 4F*6B@!,4M%% !1110 4444 %%%% !24M% "8HQ2T4 1R310
MKNED2,=,NP%)%=6\S%8IXY".R.#7E_QRM(K_ $30;.;=Y4^K0Q/M.#M;@X_
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MXH N4444 %%%% !28I:* $Q2T44 %%%% !1110 4444 %%%% !1110 4444
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M'!*YR>>U0^-9-5B\&:L^AJS:DMNQ@"CYL]\>^,X]Z\(\+W"-_9Z^$_ -Q?\
MB*#YKG5-3+!4F/5CSCKGKC% &AI?C;XE67B#4?#.J6-GK5Q"&,EG<;8Y)XS_
M ,\R,!ACM@\5A:-JUM8^(+GPAK.BZI;>&]5G0FPF#"2TF)!^0CJN>/I7:B#4
M?B?I]W));II'CGPW<[$GA;"LPYVD^AY]?R->O:=;W,FFV+:PEM)J44:F1XUR
MJR8Y*YY% "VNBZ99V%O8P6%LEI;@"*+RP0GTSW]ZO8I:* "BBB@#D/&G@"S\
M7R6%V+J2PU.QE5X;V ?.%SDK_AZ5U$%I#;;C%&BO(0TCJH!D;&-S8ZFIZ* /
M)_B-\7(-":31]!=)=0WB*XO""T-EN.,L1U;V[8_"M[6--UF?X07=C8ZL^I:F
M]CE+Q>#/W.,>JY K?F\(Z#-IFHZ<=,MTMM19GNE1 /,8_P 6?7N/2N"\!QZ_
MX&\5R>";V&XO]%E5I]-OE7(B3^ZQ[#V]?8T <%J5_P"$-=^'NE:7HFF-;^,+
M=XHX(8+<K,LP(#%FQR.,Y->J>+? 5[K+Z3KFD7D>G^)[$1J;H_=E7&&5\=>_
M\J[B/3[.*Y:ZCM+=+A_O2K$ [?4]:L8H ;&'$2"1@T@4;BHP">]/HHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI-H\+)J$JSW2[W D<$D,0#P>3TKHD58HUC0851M4>@% 'S8O_)'/'7_8:/\
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M^&\A1MR+)D%3[$8(H \W\8"QT+X;'3/"NH-<6(U1+:=?MN!$K-EHO-_Y9KG
M]LU0\)6%[H?CG2%L] TS08+GS$N(;?6A<?:4VY!\LG)*G'(]:]9MO#FCVFA_
MV+!IULFF;=AMMF4(]\]3[GFJ6A>!_#7AFYDN=&T>WM)Y!M:1<LV/0$DX'TH
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MA)&TX XZ4 ,U_3[6^\,ZA8W,*RVSVSJT9)P0!D#CGL*\<TOP[I=QX8^'EE;
MP1W]T\EX;>0AI&\H[@3G(R!@X[5[N5# @@$'J#6#I_@GPYI;Q/8Z7% 8KAKJ
M/:S?+*R[2P&?3CTH \>\4V;>$;KQ%H?A\/;Z5/+8E[?[0T:1ARV\>83\@8@
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MN)+>*.V,&I)DX#-M .5R<ANO>OH&WU"SNKBYM[>YBEFMF"SQHV3&2,@,.W%
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M#XI$?\*UUHYX\M/_ $8M<WJGANW\3?$V*UN+_4;,1:'$X:PN3"Q_>$8) Y%
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M1Y. S;0#E<G(;/O6SI5[X$L_">M6GBF.S&O^?<_;([J,&YDD+'!3(R<\8VT
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M;3+>YO&CTK5;G3+0NDNJ0P9MPZ@Y7=GUXSTR: .W6V@2X>X2"-9Y %>0( S
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M!9?B+J_V^XCC#0KKA!\Q@,J!CKDXQ0![#;:1IMG<O<VNG6D$\GWY8H%5F^I
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MB:"SMXFB0I&4B52BGDJ,#@>U<5>?%:PM+B1SHFLOI44OE2:H+?$"D':3R02
M>^*BL_&M])\5-1TB6QO_ .RH[2-DF**(HA\S&9CUVL. ?:@#O4M+>/SO+MXE
M\\[I=J >8>F6]3]:@M]&TNT,9MM-LX3&Q9#' J[2>"1@<$UR-O\ %.PGN8Y&
MT768M'E<)'J\EMBW;)P#GJ%)XSBK^H^/(;+Q2?#UOH^I7]X!$[&UC#*D;_QL
M<\*.] '6T444 %>?WW_)>M*_[ ,W_HVO0*\_OO\ DO6E?]@&;_T;0!Z!1110
M 5Y_XY_Y*%\/_P#K]N?_ $57H%>?^.?^2A?#_P#Z_;G_ -%4 >@4444 (1D8
MKQZ2[\1^%?!VK>%/^$6N+H1Q7/DZBC+]F,+;FW.>H8 GY>YQ7L.:J7MK;ZII
MMU92.3!<1O!(8VY (P<'L>: /+H/"T'B>Q^'L.H:8U[I46G.9S\P16*)MR01
MCG.*[C2OA_X6T..Z32]'@M3=1-#*ZY9RA&" 6)(K8TK38-'TFUTVV+F"UB6*
M,N<MM P,FKF: /,M,UOQ-X(L$T"]\)ZEJ\5H/+L[W3@'66('Y=X)^5@, TNL
M:;XJU;X>ZHVL0-+?7UW#)#IL($@MH1(GR9 ^;@$G->F4U75\E'5@"1P<\^E
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M<J#D!NY%=>#D9'3VI: %HHHH *\_OO\ DO6E?]@&;_T;7H%>?WW_ "7K2O\
ML S?^C: /0**** "O/\ QS_R4+X?_P#7[<_^BJ] KS_QS_R4+X?_ /7[<_\
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M,!]1FN*3P3?+\.-2\-_:K<W-U),R2_-L4/)N&>,]*[2UB,%I#"Q!:.-5)'?
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M,9CB 4MA^#P>,GKG\:]8K@=+\!W]C_8'F7=LW]FZC<W<FT-\RR;L <=1GG-
M'/ZYKVOS^$O&>A>)([-[[3[6.59[$,$E1R",!N01BM?2?$7BW3]?T&TURUTY
M=,UA#';QVY8RVS*@8!V/#9'I5[7_  3?:M=^)YH;JW0:M90VT(?=\C(226P.
MGTK4U/PY<WNI>&;F.:%4TF4O,&SEP8]OR_CZT >>7>KZCJ&G^$KVSL;,WXUV
MYCA@B7R8B0'4$_AR?7%=+;>(O%&F:E=Z)XIATV>::PFN[.YLU81/L'S1LK<]
MP?<5"WP[UE=(T>VMM5MK:ZT_4YK[SU0MPY8J ".>H!SVS5VP\'Z_>7]WJWB;
M5;.YU#[%+9V<5I$R0PJX^9CGDL>/P% '*Z?=>(M3\;>"[RUDTJWAFTAI/)$+
M*J)E?-  . 3QM].];,?B3Q[KMK=:]H-KI":/#)((+:ZWF>Y1"02".%S@XJ[!
MX)UO3I/"ESI]]8BYTFV-G=B9&*2Q,5W;,<YXXS58^"O&.F176CZ!XAL(-"N9
M'9?M$#-<6RN265".#C)QF@!+GQGXAUN_T*V\+1V,(U73FO"]^C$0E6 (.T\^
MF*R=7^(OB&W\4W^FQ7_A_3C8NL:VVJ"2-[S@$LC_ '0&/ ST[UV.F>"SH^OZ
M+<VDZ&QTW3&L=KY\QB6!W>G8_G63XG\&>*=8U"Y2&_T.[TV<G8-4L?,FM0W!
M6-@.@ZC/- '>64\EQ8P32QK'(\:LR*X<*2.0&'!^M>500ZM;?%_7]6U,Z1-:
M:?:).Y\AFE2 !R@C)^Z_J>]>D^'-$3P[X=L-'CG>=+2$1"1^K8[^U9R^%WD\
M4Z[J%S)$]EJEE%:^4N=XVA@V>W(:@#DO^$I^($.AKXNGL=(_L3:+A]/3?]I6
M _Q;ONEL<XK3D\1>)]7\;R:3H1TZ/3H;>VNY)[J-BWER<E5P>6(_*J!\!^,I
M-)7PQ-XELCX; $1D%NWVMH0?N$YV].,^E=9I?AN73?%VHZHLD7V2XM(+>*(9
MW+Y8(Y[8YH T]9TJ#6]'NM+N9)H[>Y3RY&A?:^WN ??I7GNKZ1H5WXGT/1?"
MVFVL>H:9=1SW5Y:QA1:Q*.4=UZLW VG)[UWGB6SU6_\ #M[::+=QV>H31[(I
MY,XCR>3P#SC.*XGPWX7^('AV"VLK:Z\+16*R S"*WE\R09^9BQZL1W- %?Q]
M>IXLLM=TZ.Y6/1])MI&N&$@4W-TJDK&.>57@GU.!VKO/"TBR>%=)975O]$B!
M*D'G:/2N;\0?"3PGJUKJ,L&C6R:G=)(4N'DDPLK X8@'UYZ5T7A7P[:>%O#U
MKI=G#'$L:@R>625:0CYFYYY- '(>+9=97XHZ1'H,-NU_+I<R+)=$^5"-XR[
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MT;Q#'F-FZ6]V,Y4GL' R/<&NWL?"=UH_B;5+G3)X(]&U2(O/9L"#'<XQO3'
M#=QZU';^!TE^&L'A74I8WEBAVK/%G]W("2KKGD$'% '(:-X@7PU\"GO/-6*>
M2:>V@9S@+(\K*"3VQR?PJ3X>:GH>A^,'\-Z1J]I?V5]9I<(T$H?;<( LF?\
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MS-:W03<,$89''=36''X0\5Z]?VC>,=8T^73[.99TL].A9%FD4Y4R%N< \X%
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M<$GB60 CN 0>:X"[^*GP]ED@CO$ED:W?]P)=+D;RV']S*\'CM7I6*XSQ@?\
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M_P"$EO/$%M?;D<W6EM;-;N!E2#C!!P1@^U>A>-]0N=*\$ZQ?V<IBN;>V9XW
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M>>6U&KV<5VL]N\0*,^<?,!D9 K=\811P^,O!,\,:K<?;9( 5&#Y1B)*_3@4
M=-/KVFVVN6NC27*_VA=(SQP#EMJ]2<=!]>M:5>:OX;T[P_\ $WPV]FDCW%TE
MX]Q<SR&264[5QECV'8=!727?CW0;+Q,OAZ:6Y&H,ZH%6UD*989'S 8[^M '3
M4444 %>?WW_)>M*_[ ,W_HVO0*\_OO\ DO6E?]@&;_T;0!Z!1110 5Y_XY_Y
M*%\/_P#K]N?_ $57H%>?^.?^2A?#_P#Z_;G_ -%4 >@4444 %>>'X>Z];7U_
M+I7CF\T^VN[F2Y-NEE&X5G.3R3DUZ'6;I-[=7-B)-2@@M+@R.HCCG$@*@G!S
MZD<D=J *WAO1]5TBTFBU77YM9E=]R2RP+$4&/NX7KZU1N?"#2MXEDM]3DMY=
M<1$+B(-Y ";#CGG(S6_<ZA;6VGSWID5H849V96!' SC/K6!X+\2ZCXETA]5U
M#3(-/M9,/;%;D2%XR,Y;'W3[&@#;TO2K?2=&M=+@4&VMH5A52.J@8YJCX5\.
M#POI+:9'>/<6ZS220!TVF)&.0@YY SUK9CFCF7=$ZNO3<I!%(EQ#)NV31MM^
M]M8''UH YU_!MI)XZ7Q09F\S[,8&MMHVLQXWY]=HQ6;8_#/3[3P;J/AV2\GD
M2]F,IN0-LB'(*8Y/W<#'TKH/#_B*S\1V,UU:@JD5Q) 0Y&?D8KNX/0XXK4CG
MBF!,4B2 <'8P./RH X.S^'.H+K^EZQJOB^_U.YTZ0M$DL**FTJ01M'?G[W6D
MO?AG>7WGV,OC#56T&=B9-.=5<E2<E1*V6 S^5=#XM\2+X;\-7^J0QQ7,UJ%)
M@,FW.6"\XR1U]*W89/-@CDQC>H;'ID4 -MX$MK>*"(8CB0(H] !@5Y'X5\%7
MVM:-?M%XDU32[2ZU*Z6[M(E4B5?,(^4D93(ZD=:]=>>&-U1Y45V^ZK, 3]*2
M6:*$!I94C'J[ "@#C+[X>+'-!<>&=;N_#\T=NEL_V=%E26-!\NY&XW#UJP_@
M42Z!;Z;/K-[<SI?1WTMW<GS&D=6S@#.%7V'2M/Q/X@;P_IUI=1P+<>?>0VV"
M^T 2-C=GG.*30_$#:O?:W!+"D"Z9>&V#A\[P%!W'CCK0!+-H"S>+[7Q ;E@U
MO:/;"#;PP9@=V?PZ5RUS\,KCS;NWTSQ7J6FZ->2-)/IT**P^<_.$<\H#[5WT
M4T4R[HI$D7.,HP(_2LSQ+KD/AOP[?:O,AD6VB+B,$ N>P% %.S\(6>GZYI=_
M9RM%!IU@UC%;;<@J2#N)]>*J)X%B7P7J?AS^T'*7TTLIG\H93S'WXQGG'2M#
MPYK%_J&AQ7VMVEKITTI.V)+H2KM['=TS[5MF6,*K%U"MT.>#0!BW_AI+^^T&
MZ-TR'2)"ZJ$!\W*;,'GCUKGI?AS>PSS0Z/XOU32](G=G>PA16V[CEA&YY0'/
M;I7=QRQRKNC=77U4Y%<9XB\5^(K/Q4NA^'_#]OJ<@M!=2-+>"':"Q7N.>E "
MZIX >:^AO]$\0:AHUX($MIY8\3?:(UZ;]_5O]KK3]%\"R^'M(O[+3==N8Y+N
M]%V;EHP[CD;E.?O9 (S[U-H6L^+)[J8^(_#MGI-C'$TAN$OUEP1V( X&,G/M
M4>@^/;+Q+XKN=*TR%Y+2"V$PO6!59CN*_("/F7C[U '7YK'U?P^NK:OHVH-<
MM$=,G>8(%SYFY=N">W6LWQQXQ_X0_3[66*S-[<W$I"P*2#Y:C=(_0_=7FNEM
M;J*]M(;J!@\,R"1&'<$9% &9J_A]=5U?1K]KEHCID[3! N1)N7;@GMUK)U?P
M#9ZUJFJ7MS>3HU[' (S#\KVSQ$E75O7FNOKS;QG\1M:\/^+8] T7PPVL3/;"
MX(CE8,!G!X"G@<<^] &WH7@_5+#58[_6/%NI:NT (AA=5AC7(P2RI]\_7I6O
MXC\/6GB;1WTZ[:2,%EDBFB.'BD4Y5E/8BN+\*_$_4M4\4P^'O$7ABXT2\N8S
M);>8Q(<#KP0#V//M7I= '!Z?\.[N'Q#IFN:IXHOM4O+!GV>=$JJ49<;0!P/7
M/4U#<_#*?S;NWTOQ7J6FZ->2/)/IT**1\Y^<(YY0'VKN-1O8M-TVZOISB*WB
M:5S[*,UQ7PV^)'_">"_CGT\6%Q;%'2/S"V^)APW(% &C=^!(OMN@7.D:C+I;
M:.GD(L<8<2PG&8SGIG;UK,/PP"O=-!XAO8/]+:\T\Q(H:QD<DO@_QJV>0?2N
MGO/%_AW3IKF&]UNPMY;7;YZ2SJICW=,@^M9_B;Q_H?AOPL-?:ZCNK>48MA X
M;SV]%/3ZT )H?A"YL9;F;6_$-]KDT\)@*S@1Q+&>H$:\9/J:Y^[^$DMUIDFD
M-XMU/^QEP;6R=%80D,",MP7 Y !]?:MF+QU#?ZSH5OIDFF7-EJ2,7F^W*)%9
M0<A$ZO@C!QTK>U_7[#PUHESJNI2^7;0+D^K'LH]S0!HQ)Y4*1@YV*%SZXKD;
M#P#'8?V/C49'_LV]GO!F(#S#+GY3SQC/6I="^(7A[6=!LM3?4K2V^U.L7DO,
M-R2L,B,_[6".*WY=7T^#5(-,EO(4OIT+Q6[. [J.I [B@#GT\#1IX&OO#/\
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MJ&M27ENUJWF8B1(VZ[47C=S]X\UO:M=7UI;PO86L5S(TZ(ZRS"(*A/S,">I
M[=ZN-<0I]Z:-?FV\L!SZ?6@#SD_"F^FCL8+SQIJ5U;:=-'+9P/"@6/81@-C[
M_ QD]*VIO $-QK.MSS:C.VF:Q'BYT_8 /-P )%?J",#%=<9HA*(C(GF$9";A
MD_A33<P#:#/'\QPOSCD^@H XS3? NJ6U_;OJ'C35K^QM7#PVA"Q9(^Z'=>7
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MD;6BW6&C:3 W$9X)ZUZ;/\-_!US?W-]/X?LGN;D$2L5.&SU.,X!]QS5B_P#
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M%6W@#6[#7X;<^)M]SY\<L>;MYLDJRG[Q'0Y'& :]8\"'_B@=!.<_Z#%_Z"*
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MYB\R\:]6:.0"2*9F)W*<8'4\$'@U?TO2X-)LA:P%V&YG>20Y>1V.69CW)/-
M#[?4;.[N+FWM[F*6:U8)/&C9:-B,@,.W%9Y\6>'A LYUJQ$3(\@<S  JAPY!
M] >#7$^.+R;PEXCNK^S4F3Q%9"RBQVNE(5#_ -\O_P".UFZYIWAWPWXL\&:=
MKPB;3;/394W3KF,2 K\S]L9SUXR10!Z6FK0ZUH<]YX=OK2[?8WDR(P>,N.QP
M?PIWAW6H?$.@VNIP\"9?G3NC@X93]""*XSP*VE7/CWQ%=^&40:&T$*N]NN('
MN1G)3''"XSBM3X<#_B5:NZC$#ZQ=-#CH5W]1[9S0!TW]LZ;Y5[)]N@V6)(NF
MWC$) R=WIQS0-8TXBR(O8,7W_'K\X_?<9^7UXYKS7QC UMXRN=$0.(_%GV9>
M!P#&Q$O_ )#4?G5+0'D>XO(7MY;BW\'Z=<VGD9(,LI)Q@]?]6JC(]: /3+?Q
M=X=N]5.EV^M6$M^"5^SI.I?(ZC&:+[Q9X>TS44T^^UJQMKQ\;8)9U5CGIP:^
M?GN=.\GPQ-;ZUH8E.H6S+IVEV(1H5+<^9*<OD9QR>:WO%4>FV'B3Q#+:ZUX>
MD:>9WN].U^T(DW;>1"^-Q4CH0<>E 'O88$ CD'IBLO4/$FBZ5>PV-]JMG;7<
M_P#JH9I@K/Z8!J'PA??VCX0TF[^Q-9>;;(1;$D^6,<#)Y_.O.K>?P?9:_P"+
MH?&<5J=2FO6:,7D>^26W*CRQ#GGIQA><T =9X6\:PW/@F#7?$=]966^:2,R,
MPC3ARH R>N *N>(?%$4'@34/$&A75K=B*'?#*I\R,G('.#7AE@9HM.\+3^?I
M-MIRP72V[ZY"TELLGG'(.. ^W'WJZ"TWMX-\=SKJ.CW-L\$19=(@DCMUDR,E
M2PVDD8SM/:@#U6'Q"MOJ-PVIZOID5FL%N5BR5EBDD_OY.,,<;:W+C4K*TNK6
MUN+J*.>Z8K!&S8:4@9.T=\"O-?[&3Q#XA\5:2S;3<:+9JC?W7"DJ?P8 U!H-
M]?>,Y-0UF%)%N=(TAM/@1>OVQDS(1[@A10!Z''XK\/S:N=)BUFQ?4 <&V6=2
M^?3&>M/O?$VAZ;=BTO=6L[>Y+(@BDE"L2WW1CWKYVM"7\+VEFNK>#K>X4IM1
M;*8ZBDP8'G WE]W4]/PKUG2]+M+[XLZS/?6T-S=6^G6GEM*@;RV.<LH(X.1U
MZT =;<^*O#]EJJ:7<ZS8PW[D!;=YU#DGIQFI=6\1:-H0B.K:G:60E.(_/E";
MOIFOGF%I8M-U:UU34O"%O=O<3_:H]5M)&OMQ8\@@98],;:[#2)-#TWQ*TGCV
M2TDDDTFU%E<ZA$?*= OSA0X^5MW4$9H ]!\'^(+K7YM>%PT+166I26UNT2X!
MC !!)R<GGK1?:UJ*^/(] MC D,NE27*LZ$D2A]J]_N^U<[\'SI_V'Q%_94;1
M6']KR_9XV!!5,#'!Y'XUJ7)_XO38C/\ S Y/_1M %_P+XAN?$?AT3WZ)%J5M
M-);7<:# $B-@X!Z \'\:;X7U^^\0ZSKLH\D:/:7'V2T95^:1U'[QMV<$9X''
M:N3\3:I/X#\3:U+:J=OB"U#V2#H;X$1D?4AE;\*[SPKH:>'/#%AI:G<\,8\U
M^[R'EF/U)- %]=1LWO9K-;F(W,""26+<-R*>A([#BH$U_2)-/@OTU&V:SGD$
M44PD!5W)P%![G/%<'\1YI- UF'5K??OU6QDTG*CCS68>43_WTWY5E^'],:V\
M867@J/?]ET2\?4WR.&5D!C'_ 'T[?E0!UGA?QU9WMA -;U*PMM1N+J:*&#>$
M+JLA5< G/:NBU?Q%HV@1QOJVIVEDLAPAGE";C[9KQY/#VD2?!KQ#JCV4+WS7
M4\GVIE!D1EFXVL>5 QT%1^)Y+J#XA37%U>>'K:.33K86K^(+=I(V3;\WE'[H
M.[.>] 'M,NM:7!I\-_+J%LEG,5$<YD&QR>F#TYJJWBWP\FD#5FUJQ&GES&+D
MS+L+ X(![G->/0V@N/ART$]W97EA/XC@""QBDCMPI<;U0..5)STXYK2^(]G_
M &5XST00+H6GZ5'9R+;_ -J6Q-FLQ;YN%&%<C')H ]=T_4['5K-+S3KN&ZMG
M^[+"X93^(JGJMY<6VJZ3##>V,$=Q,RRQ7&?,F 7.(L=QU.>U<+\*1(VJZ].F
MH:1=6TABW+H\$D=NLF#DJ6&TDC&=I[<UN>,./&'@K/>^E_\ 11H V1XR\-&Y
M@MO[=T_SYW*11^>N78'! &>N>*LZMXBT;0A$=6U2TLO..(_/E";C[9KQY/#V
MCR?!CQ!J36%N;[[7<2_:B@\P,LV!ANHQBMF2Y\-V7Q O[CQD+4)/IUM_9\NH
M*&BV!?W@7/ .[)QUH W=/\6ZEJ,&K.+_ $NU6UUP64,LZG9)#D?*"#RYSP>E
M=1)XGT*'6%TB75[)-18@"U:91(2>G%>,:6;#_A%+_P#LJ,Q6'_"70_9T<$%5
MW+@8/(^E:GA^Z\!VNB36OB>&V;Q NHR-<12QEKMYO-^4KCYR/NXQQB@#U35_
M$NB:!Y?]KZK:6)ESL$\H0MCTS6+XB\?Z1H-WH<;WEFT.IRX\YIP%2+:3Y@]1
MG _&N$\8WNGS^/M4AN[W1-$,%M"K7.HVGVF>X4KN_=*_RC'3 &2:Q=!;2D\&
M^!K[4S;/90:S<1RW%S&NU4^? ;/W1G!QT% 'MNI>*M T::&'4M9LK2689C2:
M95+#U /UJ?4M<TK1[);W4M0MK6U8@++-(%5L],'O7A>H2S6WC+Q+]MO_  G;
M/+=;D&OVS/(\&T;/+;&-FWH!5S0AIFGW?ABX\7W%M<Z,+"=+&XGA=;99/,X&
MV09'R8 +#ITH ]+\/^*)-;\8:W8136T^FVL-O+:RP\[Q(I));."*TO$^LR:+
MI(DMD62]N95MK2-NC2N<#/L.2?85Q'PWDT27Q]XND\/(B:<ZV[)Y:[48D'<R
M#^Z3TQQZ5N^-./%'@MG_ -2-2<$GIN,3;?ZT ;VHZ_I7A^"V&MZM9VDDH"@R
MR",.PZX!-9'ACQ4VI)XBN-2N+6*TT[4)((I@=JB)0""Q)P>O6N:U*?PU8?%'
M69O&0M%CFLX/[/DU! T7E@'>$SP#N[=:Y"WN])MO NMK9V5M_9<WB41P&_5_
M)M5(!5Y%!R5&.AXY&: /:;#Q9X>U2VN;FPUFRN8;5=\[Q3!A&N,Y/H.*MR:Q
MIL5I;7<E[ MO=,J02%QME9ONA3W)[5XSX+&GW'Q8-M%K.GZK'/I$J3?8+1;>
M 9890;>'X/7KS6MX8BN;OQ5IGA6Y#M%X4::61R,!\G;;_P#CA)H ]>HHHH *
M\_OO^2]:5_V 9O\ T;7H%>?WW_)>M*_[ ,W_ *-H ] HHHH *\_\<_\ )0OA
M_P#]?MS_ .BJ] KS_P <_P#)0OA__P!?MS_Z*H ] HHHH *J_P!GV0M9+46=
MO]GD)+Q>4NQB3DDC&#S5JO-O%5UXI7Q1H;S2PV.C_P!KQP1P0.3)<@ACO<C@
M+Q]W\Z /0GM;:1X7>WB9H#F(L@)C.,?+Z<>E,_LZR^R/:?8[?[*^=\/E+L;)
MR<KC!YKGO&%]-H5QI6MQO)]GCN5M;N(-\K1RG:&QZJVW\S75T 5K>PM+.U^R
MVMK!!;\_N8HPJ<]>!Q4=EI6G:;O-C86MKYGW_(A5-WUP.:FN[N&PLI[RX?9!
M!&TDC'LH&37FG@C5M8M/$<,FMS3&#Q/$]Y:I*3BWD4G$0!Z9C*G ]Z /39X(
M[FWEMYD#Q2H4=3T*D8(K(T#0CI6D6MC>&&Z-BS+:3,F76/HO)'#;>#BL?7/B
M+;:/K]SHD6BZMJ-_!"D_EV4(?<C=3UXQ[U&/%.CZ]+X3U"!]1"WMS((%C?RU
M#A#N69<_,!@\>M '9K;0)</<)#&L\@"O($ 9@.@)ZG%2UY_)\6M+CW2?V3JK
MV<$[07EVD(,5J0VW+MGOUX[5=TWXCZ?J7B*VTK^SM2MH[P,;&]N(-D-UM&3L
M/7ISR* .FO-(T[471[[3[2Z>/[C3PJY7Z9'%6P H 4  #  K@KSXK6%I<22'
M1-9?2HI?*DU06^(%(.TGD@D ]\4A\10Z1XV\4ZC?74O]F6FG6LP7<65<YY5?
M4\4 =TMK MR]RL,0N'4*TH0;F4= 3U(I@T^R%H]H+.W%LY):'REV-DY.5Q@\
MUS.@>/8]:U.*PNM!UC2I+A"]L][!A)@!DX8$C.,'FN@UK5%T;1;S4W@EG2UB
M:5HXL;B!R<9XZ4 3BQM0\CBVA#RH(Y&$8RZCHI]1[4VRTVQTV-H["RMK6-CN
M98(E0$^I %8DWC?3(=9T+3-LK2:S$98'7&U1C(W<]^<8]*S;[XEV%K--;6^E
MZC?WBW4EM#;6D8D>;R\;W&#PH/&3CI0!U0T?31?F_&G6@O#R;@0+YG_?6,U2
MET62Z\60:O<R(T-G T=K$,Y5W^^Y_  "LN'XA:=)X:U/5YK.]M9=,&;RQN(P
MDT6<8R"<8(.<YJO_ ,+(M%T7^TIM%U:$S3B&QMF@_?7I(R#&N>F.YQ0!V,%K
M!;*RV\,<2LQ=A&@4%CU)QW--2TMX[J2Z2WB6XE 624( [@= 3U.*PO#?C&#Q
M!<SV4VFW^E:A"HD-I?Q;'9"<!U[$9XJ'XB:W>>'_  -J>H6$4[W21X1X5#&(
MG^,@]A0!T<]I;W)C-Q!%*8FWQ^8@;8PZ$9Z'WIG]G67V1[3[';_9I,[X?*78
MV3DY7&#FN('Q+%I8Z1%/X>UF74[ZU,L=HD2F5MIP21G@'[V?2I)OBG9I/*T.
M@ZU<Z?;L4N=0@MMT,+#[X)SD[>Y&: .MFT+2;A(4GTNQE2 ;85>W1A&/1<C@
M?2K+VMO(\3R01.T)S$60$QG&/E]./2N>U[QQ::.+-+33[_5[F\C\Z&#3XMY,
M?]\G@ ?C7)^)?B;-+X0BU#1-/U*.Z74H[2ZA\I?,MV# LC#IE@<#'<T >J54
M&EZ>'N'%C:A[GB=A"N9?][CYOQKE]3^(<5A):VL&@:Q?:G+;K<2V-K &DMD;
MIYG. <\8S3[CXCZ/#X>@U-(+V6>XG-M'IR0G[29Q]Z/9V([]J .DATK3[<(L
M%A:Q"-#&@2%5VJ>2HP. >XI_]GV7V:*V^R6_V>(@QQ>4NU".A Q@8KSO0O%,
MOB'XL1)]GU+3Q%I+"?3[Q2A1_,!#%<X.0>M=QXAUZ#PYI?\ :%S#+) )8XW\
MO&4#,%W')Z D4 :!MH#<K<F&,SJI192HWA3U /7%5QI&FK?F_&GV@O#_ ,O
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M7%IK*:9\0/%-Q?W;II]GIUO,0S$H@PV2%]3[=: .T@M+>V\S[/!%%YC;W\M
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M(QC!4_PD<Y]:Q)=!UZ^TB[U6ZTB2"ZU37K6[%B@#M#"A W/CO@9->N=Z,9H
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M5_'G\Z['5K'3Y'MM4O9/(;3F:9;@-MVKC#!C_=(ZCV%97_"R/!7_ $-&E?\
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M!G.T_I73W]G'J%A<6<KR)'.AC=HVVMM/!P:DMK:&SM(K:W01PQ($11T  P*
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M+(A0E&VD C'!'0^]><2>!?&-Y9#P[?\ B>VF\.9"O)Y+&\EB!SL9B<>Q/7%
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MQDMFC.=Y9F!!';'%<KJGPTN[^YU&_BN[);YM2:]LQ/!YT15D"E)4(YSCJ.E
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M(T7 (*_/][KG(JWH^O:\OAWPKX=\,PV?]H3Z6MU-<WNXQ0Q#@<+R23D5;L/
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MB5EN5"D*3D_+C=GBNGCNXS9PW$SI$)$5OF8 #(SC)J;S8PH8NH5L '/!SZ4
M<5=?#D-IFC)I^MW6GZKI-O\ 9X=0A1270]59#P1[=J2+X;Q_V'K5M>:S=7NI
MZNBQW.HS(-VU?NA4'  ]*[6.:*4MY<B/M.#M8'!H%Q"93$)4,@_@W#/Y4 8U
M_P"&EOK[0;HW3(=(D+JH0'S<ILP?3UK=HHH X-/AL8X[NV77+@V$NI)J$-LT
M*D0.'+L V<G<3WZ5OWWAB#4/$L6KSRED2RDLGMBF5D5SDDG]*W:* . M_AO?
MV[1V:>--870XV&RP7:K!0<A/.'S8_IQ726GAV.U\3ZCK7VAG-[;Q0&$KP@3/
M.<Y.<UMT4 >8W7PBN+C2Y]&7QAJ<>AL6:&Q$:8C).X MU903TXJ&X\-7VH_$
MO44L=;O-+N[72;5$O((PRORP8,K<'H/I7JE)CCK0!Q$MEHOP\\&WS:A)>WXO
M9&^V3F,R2W4K@CD*.,]!V'%4?#7AS5=!^&=O;64EQ!JUQ.ES*54,_P T@)1M
MWHG!/M7HN/>C% "CIS7(^(? YU35QK.DZS=Z)JQC$4EQ;J'69!T#H>"1V/:N
MNHH Y+0/ L.EW%W?:KJ-SK6IW<1@ENKH  1?W%0<*#WQUK%'PJE,*Z5)XKU-
M_#:L"-**KC:#D(9/O%<]O3BO1Z* .=L?"<=B?$&RZ)76'W%?+ $(\L1X'//
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M'X9\4ZOXKO?%]R&U"RO)(4$MR8_L<"CY&09'4?-GGFO5["PMM,L8+*RB$-M
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M^)/A;RK;1],-X95DM]/O9)Y9$V$YE).",CL.N:]DL?">@:;HDNC6>E6L6G3
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MEBRMC&<DYZ'ITH \HM=$TNR^&MZ=/B6VN9O$"V\LD3G>J+<%4ZYQ@'BNEN/
M>AVWQ&M=$MXKB+2[_3Y)[ZU2X?;=.K@ OSD_>.<$9KNO^$(\-_:+R?\ LJ$2
M7LR3W!#,/,D1MRMC/&#SQ6H^E64FK1:H\"F^BB,*39.50G)'IUH \2U43Z!X
M.\1Z/I#21V$?B*.U6)K@QB.%@"R>8?N*3@9]ZN>$K"]T/QSI"VF@:9H,%SYB
M7$-OK0N/M*;<@^63DE3CD>M>M#P]I/E:A$;"%H]1<R7:.-PF8C&2#]!5'0?
M_AKPS<R7.C:/;VD\@VM(N6;'H"Q.!]* /(D\(:4_PPU?Q,1,-8MKR>6VN1,P
M,!6;@* < >OUKK-"T31W^,=]?RVD0OAIMO=1R%B#YK[@[ 9Y)%=X/#6CKHD^
MC"Q0:=.6:6#<V&+'<><YY/-)-X8T6?6++5Y;"-K^R3R[>?)#(N,8Z\\$]<T
M<C\43#>/HFBM:?;9[R:1DMIKW[-;N$7)\TCEL9X45YY802:9H_Q#TD/IZ00V
MD#BWTZ5W@B<GD L2=W3/O7N>N^&M'\36:VFLZ?#>0HV]5DR"I]01@BJ%KX!\
M+65K<VUMHMO##=0B"=$+ 2(#D \\\]^M '%/I.B^*/'UUI_BAA-!9Z;;-86<
MTS1QL&7+R#!&XYXKG[RV@G\*ZKH5E>S2Z+;>)+:WLI5D),:D@NB/Z*20#VKU
MS7/!GAWQ)%!'J^DV]T(!MB+9#*/0,"#CVJ8>%M$32;;2TTV!+&VD66*! 557
M4Y#<=3F@#SV;0[7P1XYN$\-126RW&@W,[0!V</,A^5\$G+5P-E9:@OAZVUZV
MT+3H=1^28:])XA E:3</O*3CG[NT_2OHM]*LI-6BU1[=3>Q1-"DV3E4)R1CI
MU%8B?#KP@FL_VNN@68OM_F"0*<!O7;G;G\* .AMY=\,8D9?.,:LZA@<9'\JF
MJFFE62:M)JJVZB^DB$#S9.2@)(7TZDU<H **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS^^_Y+UI7_
M & 9O_1M>@5Y_??\EZTK_L S?^C: /0**** "O//B.NHV_B+PCJ]CH]]J<>G
MW,\D\5G'O<!HPH_7^5%% #_^%E:E_P!$^\5?^ R__%4?\+*U+_HGWBK_ ,!E
M_P#BJ** #_A96I?]$^\5?^ R_P#Q5'_"RM2_Z)]XJ_\  9?_ (JBB@ _X65J
M7_1/O%7_ (#+_P#%4?\ "RM2_P"B?>*O_ 9?_BJ** #_ (65J7_1/O%7_@,O
M_P 51_PLK4O^B?>*O_ 9?_BJ** #_A96I?\ 1/O%7_@,O_Q5'_"RM2_Z)]XJ
M_P# 9?\ XJBB@ _X65J7_1/O%7_@,O\ \51_PLK4O^B?>*O_  &7_P"*HHH
M/^%E:E_T3[Q5_P" R_\ Q5'_  LG4?\ HGWBK_P&7_XJBB@ _P"%DZE_T3[Q
M5_X#+_\ %4?\+*U+_HGWBK_P&7_XJBB@ _X65J7_ $3[Q5_X#+_\51_PLK4O
M^B?>*O\ P&7_ .*HHH /^%DZC_T3WQ5_X#+_ /%4?\+)U+_HGOBK_P !E_\
MBJ** #_A9.I?]$]\5?\ @,O_ ,51_P +*U+_ *)]XJ_\!E_^*HHH /\ A96I
M?]$^\5?^ R__ !5'_"RM2_Z)]XJ_\!E_^*HHH /^%E:E_P!$^\5?^ R__%4?
M\+*U+_HGWBK_ ,!E_P#BJ** #_A96I?]$^\5?^ R_P#Q5)_PLC4?^B?>*O\
MP&7_ .*HHH 7_A9.H_\ 1/?%7_@,O_Q5'_"RM2_Z)]XJ_P# 9?\ XJBB@ _X
M65J7_1/O%7_@,O\ \51_PLK4O^B?>*O_  &7_P"*HHH /^%E:E_T3[Q5_P"
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M^*HHH 7_ (63J7_1/O%7_@,O_P 51_PLK4O^B?>*O_ 9?_BJ** #_A96I?\
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ME_\ BJ** #_A96I?]$^\5?\ @,O_ ,51_P +*U+_ *)]XJ_\!E_^*HHH /\
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# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>syn-20240422.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWamEKbOdzZR+WYkxtmB+bZlq/yEneOcLTiBrILpmkVEO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:syn="http://syntheticbiologics.com/20240422" elementFormDefault="qualified" targetNamespace="http://syntheticbiologics.com/20240422">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://syntheticbiologics.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="syn-20240422_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="syn-20240422_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>syn-20240422_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>syn-20240422_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://syntheticbiologics.com/role/Cover" xlink:href="syn-20240422.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://syntheticbiologics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2412300d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2412300d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  T ,(# 2(  A$! Q$!_\0
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M/'>J6WAWXDZ1HGCYGO/$&E^.=6\(_'GX37EI:VNE6VC?#W2M1C^QF3PY(O\
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F7Q2_]*D<M'$5Y4:,I5JCE*C1E)N3;<I4J4I-NVK;;;?5MOJ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140550871594384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 22, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 22,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12584<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">THERIVA BIOLOGICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000894158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3808303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9605 Medical Center Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 270<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rockville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">417-4364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TOVX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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M-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @
MB8266 =!36*!    L0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    " ")A)98N-])UNX    K @  $0
M@ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " ")A)98F5R<(Q &
M  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+
M 0(4 Q0    ( (F$EE@<#IBF9P0  "D1   8              " @0T(  !X
M;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " ")A)98GZ ;\+$"
M  #B#   #0              @ &J#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( (F$EEB7BKL<P    !,"   +              "  88/  !?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( (F$EEBJQ"(6,P$  "("   /              "
M 6\0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " ")A)98)!Z;HJT   #X
M 0  &@              @ '/$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " ")A)9899!YDAD!  #/ P  $P              @ &T
L$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #^$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2412300d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://syntheticbiologics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>syn-20240422.xsd</File>
    <File>syn-20240422_lab.xml</File>
    <File>syn-20240422_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2412300d1_8k.htm">tm2412300d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2412300d1_8k.htm": {
   "nsprefix": "syn",
   "nsuri": "http://syntheticbiologics.com/20240422",
   "dts": {
    "schema": {
     "local": [
      "syn-20240422.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "syn-20240422_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "syn-20240422_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2412300d1_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://syntheticbiologics.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-04-22",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2412300d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-04-22",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2412300d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://syntheticbiologics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001104659-24-050037-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-050037-xbrl.zip
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MI6H&E<;@J^"=08YO+PQH@'&3H2,B(/0&V(1N..21* _]@(I@5(OV='Z6'K(
MDOCS_IX\$*'>.UB27?99[NBIXPQC0*SKL[?!S3%/YGH#@X#PK6ZA4[T4U2M
M*_6,6%D%^EU5@O):;+]?7M]T+3_)S7J3_&N%4R*W_!=02P,$%     @ B826
M6%-CR*U=!P  Z%<  !0   !S>6XM,C R-# T,C)?<')E+GAM;,V<77/:.!2&
M[W=F_X.7O28$Z'XD3;:3T-!AFC;9D+:[>],1M@!-9(F1Y #_?B4;4SXL^>3&
M)[E(B#F2SOL<6?:Q)%^\6Z4\>J9*,RDN6]V3TU9$12P3)F:7K2_C]M5X,!JU
M(FV(2 B7@EZVA&R]^^OGGR+[<_%+NQT-&>7)>?1>QNV1F,JWT6>2TO/H Q54
M$2/5V^@KX9D[(H>,4Q4-9+K@U%#[1='P>?3;2:]'HG8;4.]7*A*IOCR,MO7.
MC5GH\TYGN5R>"/E,EE(]Z9-8IK *QX:83&]K.UV=;GZ*XA><B:=S]VM"-(TL
M+Z'/5YI=MER[FV:7_1.I9IW>Z6FW\\^GVW$\IREI,^&XQ;15EG*U5)7KGIV=
M=?)O2],CR]5$\;*-?J=T9UNS_98%['<\T>Q<Y^[=RIB8/.RUS41>"_=?NS1K
MNT/M;J_=[YZL=-(JX><$E>3T@4XC]]=&;]NJ7@LSIX;%$R:YG+$X#UW'F74&
MTG9-ZW->P5S1Z67+FMMF>F].W_1ZKI%?]VS,>F%[J&:N@[6BSIX#"T4U%2;7
M?&L/[!6A*V/[%4W*BESS+W?1,..*;?I/-VJ[SI:EME7[L;#<N%0ZQ66\YP=W
M09$'FLL.GJ/7-#Z9R>=.0ID-0:_O/C@B_9R&_>=[WM#51!M%8E/6Q,F$\KS^
M[];FP*33@%<EB4=;8[53^Q:'/NV&[TK%D50)599U61=1\5[0COOJQJ*S(,I6
MU([GC&_C/54R]='9D) >1W=!V2::H7EEVT^<#T-.9M4X#TR /+L80"O58!%]
M3W6LV,)QJ0&[9PGDVT/E6Z&M8<SEN?- 9\SYZUQQ5V#J#H;'!4\1(/@^YD@1
M5(L4@2LA,L(?Z$*J&O#[ED#>;S!Y5VE#POQW1I2ABJ\AI(^,@;!_PX3M48C$
M^U$1H9GC P%^; TD_COJC8='(Q+R\9QR[K(Z(D"]O,H>B/T/3.Q^G:\ _,VS
MN[[;2PN<_4X1(/X_7PO^([5($;BGBLG$7M(5@/V1,9#Z&29UCT)4WC<B@=+>
MFH+S'WS8!_*04 ^9C@DO/!K:8SJ,N\(<BAPEYZR5B8K]7TH4&/J.,10Y2AI:
M([%AX(-,J3UG@J.*WQJ*'"4!K1/9,/,;89A9NVF SUDZ^?'@=)_UL164,4K2
MZ1.%PK9\TB",F]T(\3VTA#)&R35#XE X#ZP>1?A()'3UD:Y#H(],H:11<LR@
M/!34]XJE1*W'+*X?-(YMH;!1,LNP0!3:CV0U2JPJ-F7%_& ]=&\1*'N4M!(D
M%R4$(Q%+M9 [CXL',K/GXWH@D^"07E,0&@Z4?/,%TE&"<I4D%I?>_+EE@G9#
MH:@T!\\1X04@(/.58.^]#'L/CATE#ZV5^4JP]U^&O0_'CI*+ULK$Q#ZP'^_4
MHUQZ9J"]QE#D*+EHC41,X/F5YD[=*_G,BF52==2/2D#1(Z:H8;&H';ZXR$-Z
M>VD)Y8V8KE:+P^1\+[4A_#^VJ+N3K+:',D=,7$-"FW[ 6,3=/;3P+24Z,('R
M1<E5*^4TC=1%6%'B[[[[%E"@* EHE9B&>=Y*-_<QER+X//;8"LH5)9/TB6IZ
MX'5+BK7WU-_Y&KR"#658/931,,9OBAGKP4"F:28VSV@\LV(>4RA>E/0O**]A
MU&/)6<P,$[-/]@Y1,<*K.5?902&C)'M^80T3OE?419K:V^Y\'9?;<Z#NIE/?
MR!NRAQ)'R?7JA>*2'VF=4?52_A6EH%% 2?N@HIL>9VB<V6%OW>U-'MV.&<\H
M<V0%98V2\OE$-<SVLWQ4Q&W?&Z_3B>3^[2&5AE#"* E>0%K#D/?\J,9[8 (%
MBY+95<I!&A-N5O&<B!GUKUZHMH0"1LGT0N+0QMX9:.R=O7#L1<GX?**0V!9K
MP^T9=3?A;$;\.\F"!<#[;#")!Z0VO7\OW_+C-G:K-/=C:#]48_>80H'C;)$,
MR6L:=98P0Y/"I2$31,0VI=KN:_-DY_6EH ' V4,)%(WR>/\;Y?RCD$LQID1+
M09/B5C_TA-];!!H%Q#G$&KDH(?@J>68IJ7PAJ/*< QY3*'+$N4.//)RUE\6B
MYNVUIWB#1XBXKP04/.(D8E@LTOHT0YW/[)F^)X9L/ SQ]Y6 \D><4 R+15L_
MKP;VPC.3X3GS T,H;<2EL)724""/4\+Y=::9H#HXMAP80B$CKGFME(8"^2:E
M:F8'M0]*+LU\L[<S!-M3  H=<65K4"H._-6/?>3%_K<@^0IK\-L)$+%[16*]
M=B..W4**XDHN$J(\U$/V4.ZH&RO]0ALF?V?F5.W>/^7.C&S>%EKT4%\*&@64
M=!4J&N?:NK.3/WAIW;.#\D9,3*N$X>R9RB:<Q4,N2?"^?,\,RA<Q"ZV0A8+W
MFH@GE2U,O+Y7,J;439_H[=D&2(B %4!#@IB?O@@%SN,"F:9N,Y&,G\9S*UK?
M929_H:GU+_C0(%@.&AK,39P X4AW0?K'1B^:7*\?Z)0JMTSAD:[,M6WH*7Q3
M!"@.C0_J&X7 &"K"=-$YTG5K#[A7UA;?N%_NM:SVR/]02P,$%     @ B826
M6,<;/WD:%P  <8X  !(   !T;3(T,3(S,#!D,5\X:RYH=&WM/6EWXCBVW_D5
M>LR;Z>1,6&Q(0DB*.119BJY*R(-T5W5_R1&V %49R^4E0/WZ=Z\L@PV&$ *I
M9=*GNY,@Z>KJ;KJ+),[^,QY:Y(&Y'A?VF]^T?/$WPFQ#F-SNO_FMWFDTF[_]
MIY8Y&_C0#;K:WIOLP/>=:J$P&HWRHU)>N/V"=G)R4AACGVS8J3I.[:<7BUKA
MT_6'CC%@0YKCMN=3VV#301:WORR'CZW3KEW7XHFN^$DT2:FP !I:S=F >.>C
M0MB8Z.JG=CT,N_I15^Z)LJX=K\(C[#$=,%[65T.<887LT]OVAUEW/[W_K&O!
M=ZGM]80[I#ZP$"$=YHIZ3C^* <EYS$@ @K_S??'P*)Q*KJ1%<!:8DUPI-G>I
M-Z6XR>;('<T)#3!"+T4=7=9;"O:H *U1Q\#+]2EUIIU[U.O*CJHA 14^<X7%
MO-3>LB71W1"![;N3=(Q58V* Y_J+H.'#9*>)/>T$O_L#YG.CRX4E^MSP\H88
M8O=RL:SK650R1LU:AN _9S[W+58[*X0_,V=#YE."H'+L:\ ?WF0;PO:9[>?N
M)@[0W C_>I/UV=@O2$TLP*A""/+L?W(Y<LF9959)A_FGY(8.696,S?$I:9[+
M7^Z+>N/^C\X_]?.K>OT6?N Z2"ZWYN!2Y1X6>)^^R/MHD>O#*^O301N,/CRY
M9R!FL KXMSYDM@G_^9<6[=_WJ.6Q)T"JQR!=V,"-20- N=1JVB8;OV>3^R+\
M4SDI:X>5]<$>O05:G]]K]\H^A/#AHR> T.\[ ^HR[UZ_E]8PA.')SYX YAPQ
MN56@2@L(+8/=%>:$>/[$8F^R/1"^*M&*CD_N^!!ZW+ 1:8LAM0_"#PY@?I?W
M4,9-_A -,[GG6'12);:P&;;Q<17EE;F@!/(/;IK,1HW OZ#733 $.$8H[6._
MC9:C[K5Z*"&Y8CD':D2X^29[20T?V5($3;1AT3 7X]6$(&1K4A+."@G(SYFK
M')\K552RM9FLI$U<B*\9T0#CQUS8CIDGV]'$5CVY=P(Z1&Z(U8&TGZ!XN4A/
M\F//S*I6'ZP#M/*A8S&T"&J6!.!P)D\$KIH(.DFN5]7:Y3KGUJ[L5-23R?5&
M'TX_YB8V]#ASB<2;I>Y"C>;[)&GF!T\G*Z3-IN9R@(["7$ !_ #7/Z<^J\VP
MC^#,VN9'@:0L&1.US*$4GSWZ3)$O0=+ YB$]0;?FB3ADU M<5E,Z6(4N$:BH
M*0$?8:4##]5Y&7RU>-EGPPEF-F-^$E!P8-P"07&DE'7J"W?6^N2USZ.7 C,V
MXSFSQ9#;C\SY*#WF)TT!&S7'ES]/1J5Z,TT+-5Z9O+,"C*UE,IDS)[*00^KV
MN5TEQ2QX DXMWK2NS3TE4R#0%0#]ZQ_:4?%4@8OM$.W 8KE;VI>;8]Q,A^-S
MOG!@/MWQ(XBYKO!],:R2$GXVXJ8_0(2*_\PFAG>%"\L+A[^UJ/&%  SB"8N;
MIT0U1I#"=FW6CJO,>?P;;%OPZ0QYI)3Z?VP)A>0:MDRKYX([)6@,<M3B??C(
M !O&7"!5M_;'3?/NXIQT[NIW%YVS0G=;O%XZ8>>B\4>[>=>\Z)#ZS3FY^-1X
M5[^YNB"-UO5UL]-IMFY> HN/]<Z[YLW57>OF@)SG&WFB%P_+)SN?^65X>MEJ
M7Y,SSZ&V-)?H:IT4CZ4OF<N="R- /P1=]WMCZN?./-YO[/,?C:_GER/VU@!P
M&SHD)W&')#YGME;)O9]W0,X*B&WM%Z$_"'C[XN:.M"]N6^V[7V11MX'K!=3V
MB2]@H(%Q.M%*1+A$.]PS]U]":46/0("'LP<N]SD O!@; VJ#R:T;/H%F[:14
M_D7HC7X>+JG-'.'Z9"_ZFU'8U9GG$_8 G3.N;&;F?G5!XTMS&G\KO<2+T(5,
M5WW_]_?F7_SWWS\^5)ZD^F'JYDV6C_VJ"="'T'=@TLD$L&5VTC1HQ333D$ N
M6ZL[+K>(KA\0G.:'-!?E;7%ZGF\7BF]A&-=F?>YA?LS'"#J=;>U.O\SL;\*H
MZ!M;;$U;#"&3<V=K=^\NVLT_Z^1ML_6A==5L= Y(\Z:1_U[LV;L8 _(2:]0,
M=XHMH1[Q'&9@_&82#L3U/0*6 A3%W7\YB?%IUV+09%E #P.3VEF0??S;H:89
M_?UD-&+>[M2)-81E4<<#5S7Z389&9[X;P7]@KL\-:D48@T^LHJ<SWYSSER.7
MN#OO$JNI2SK,K-:0<WE_ )@7\Q5TQ5-E7 IX;)V15UU$MSI% \X3&M"T#>&"
ME9.YX8X/]J$1YD0;PERB$)<W=PW[N'O9NF6;VC%,6V.,[C/'%0\H8PN&3%_4
MF)6X9FLW[(&:=*6^J%]]<X$Y$=^?1/M((%/@K<OL\FZ9_3;![$MN,:!+E[GI
MG-5M[]OU1+N^KO0W-W6E1<;-YL5LD);3],/*ZGWGQV/4CK6RDF#4'1TW58[,
MD-*^BFM=O:YI^HG5>,<WYUI*CG,)$MF:5LJ5*L5*J5A:DX?P/W<3BYE&[ZC7
MCG8]:5;0\1;@#;OD,SC#GLE#CUSTY-ZSP^EYW,+)S3159K<B^-L2YKV&& ZY
MAV5F@HI.;D1^?Y4&[PS['8M&L]TA%T/'$A,0C*1F[%HN0I(Z<]I4D#Y0[><.
MQ5:[)W73=)GGJ1\?N,VT="-8[%[6_^]C<_+GU?'F1O!PT0BF()"MG1P5#\DU
M,]& D89<"SEW^<-"T4FIP<%"^-AX9)5Z^BJ]6_W35;$]^.O6W'R51^NL$F*=
M3L#!%.K'Q>\5@CRZ32I\&_!KR[T3(SN=:N_]3[V1N'W[U^ 95#M>2K79]-E:
M6QA?'KAEK2\)Y;05R5VHY=Z"<PQ;PA(__.Y(JXQ'7T9?WS_-6WN:'UY9NNXY
M)+.U:^I.+&J;2]:^L/2W:4N_%8"/]3=WE@<@?W-[TFR7?;?U>7-^GBQ=5P*#
M;$TO5@Z_FPKL*9PP!'=<(#-WP.2P,3,"'^P-? Q;$,P!5"??N),Q .47#,)W
MIO=[\[)25+*"RE9W&5TN'<)K?6P,KGI_MYX6GL:E0T^DT>)S9FNEHK9$&O87
M)/Q$8?U!P$YQ.Q#VRO#+/!G]_O?HKZ^?K,UK WHBTS0_;[96UHYSY=+1=\OZ
MS;)>__I'1=>.3SWH9C$'<22V1/* @)Q; ;IW&0ID)RC4OX!,WQ3JN[<7EV#<
MP1L)TW:NM/7P)PVM"%"V1\*D/CC2:+0S%O5\$N:YMV4W=DK/SX$';O<D6VL,
M& 3J6+*@#FQ>8!PQ<.N*,>DR2XQPI=B(]""5W/M,CUL@4(1[(%T^LTV@@"^
M",/ \JG-1.!9$^*!-^_U)G*D&B"Z,#%5\9]LB*5" X #U+4G45M/6# YCL,-
ME6-0Y)$]CS%RQ6SF4BO3M&%L$ :4];R>#]'=K^Z&^+O/DFZ4"E7CRQ5GO#+*
M4_WT,O9;"$,5KA]A&;@4+[O@+AXI^_O1Y3XP'2/5P%8QFY=NA+\8AQ<&_<"]
M;];&59JN$!:CMCR'-F>>$VG-5+1"@E1.EUKHY9%UJJ*LCMX5"K"T. [$B14D
M\>P%*>N'2MKGJH18'-S3CDGCLDWT4C$/'?=3<S];BU9?13SMZ$%'6-P EMC]
M:S"$8 VM=/FVCEJ^8WWN.(:V"_E.9'\7<7I9X9[-#Q(4(K HV5J9YC1]K[L?
MD^]XZ3LSE>YR,1]V?A7P%Q3P*$"^=1D:2CS;*H^[X![NMGJ]9=XTF#.C\GMI
M>'-UN M!3R3,E^/VL@(/>.2,&"*/FG6M;.96R#Y)RG[8]U7Z7U#Z]73I;WI>
MP-Q'=:#T]\>WAW[KNCC8B3-SN$('%C#\T36AQ'+E/6,]35!]7U83=A1(Q7RY
M,+)A+L1&3MJ)--3^C(IT@";;BEF6(/9+'/=845$NQ2K*%NL!QD?Y\L8%Y3N\
M3A:>83,&Q("XWGNLE!X_P+V I6I4];5ES4\ZWQ N\O YBW0I0B*=R; KK#UO
M_T=8XB(?G[/$&W7@2K*1118(M&\TX/#)3$6W561_)A54>[CPA=9MR?>2(J&R
M71--[TKY3]\%1_Z[IM$;'Q\/-J\-ZHFJV?R\V1IN?0(7((PO![!LESQ0*V#D
M?XOY8E$C#MZ3PFLH&^Q^SV30MD1S24)>J62HD>GT=VY&?7;MC8.+P>;T3]3?
M$I-F:W>M/S_],H2=E^W("UE^0O6A>1R4QHT/7\OT685 M#9I-4"]DB;[<;RR
MM9N_.A>D+N>D]AJ\^%F]I::-57_,-$^((5/0,.H+&&<FSPLE\\,9CI4Y @XH
M NZ3OBM&_@!=40=SQM0C)NMQ6QVCM56FK7A(%@_CS\[@EZ:N**[W^%0FW:(Q
M7![%=? H+J;_0\]6[^;TS'KG^^=AH[.+PQ>@YW^&8H'4[&SM(IW^:N(%Y>S1
M(;<FU<6H;*U.,T4^3)2W(R2N) Z-$(5T?78'S??MJ\I1J_PT>[EFU)92^4Y%
M;MV 3?WX\<5AIL2]%6J)Y<<Y'4<5S_"%ZL\ %)A9$!R! MM"ADJ!QV0OF%75
MF/#Q#2[#I_ B,7))3F5-<.X1AYG1&-BP(&AQV0/W8!R8!6H;F+"DAGRE COC
MRR<F=4TO(ZM+YK(XK;1']R,;$M?R_+9%/A*0W4O"4^^SEE*NLX9W7)]PGW6Y
M,[!PW_5'NL\:FPBG.(4Q7P-,A !H^<:#](,65[[TLNZC%X6/I".S>+LY3@E'
MT6%Q=I?1+[DN \4 #!V)<7S&HR6L?.*,<?)OC?(K4Q=;-64R.&SZ;$B.\T4M
M3]JL'UAA7?KRG)QSS[ $WFO/;_6,01<D <QC8)N8%A%N%<-0O$.V>S.]8O*6
M39)WV  Z>%_\@6;>1L_3')"F;>3)'MI /&JB%T\;T;X/?VFG^X1CBM(DE#CR
MB)4+MIR"_::V#7-BCDD:4&P$1WYZ! #^-BQNR[.?)O4I^' 0^>&6(&TTLP?X
M/)69 :/,<WXP!*/.>CTPS7CR@ P"( 8(N6V U/NXH6-OEXR9+?HN[?F@"-25
M%2MNP%Z"O0!'N4T >B:>*S #<-A@G,GQ.B#YLW&3@Q 3CX!9W!$>D-LB'& (
MGT&O? 9H \N2N'J!(V\\RH4)?%@(MQAO8L-6* \QQ(#UN.OY.7Q&*@5??/-#
M'I&GSD3NB4-F \UQW(A;%NDRTH,!@1LZMT!C@6F+3(*:-$0D"AM(1QB<^1.Y
M13880$%P>'!"LA=GBK.SWKEJW$7,W"?Z\1FLKN8/8!^"GZ1NVP&L[9HQR1>8
M[II.0#9#B=F6__I4T=V^37C/)L2G7Q@=T8FGCDZ!'=VB&9#31(AO$6KK@;D/
MG(VJR%[TB;KX\H92,R6(_\:DE> @U"  (,5-$ 'X0 /MM0>\RWWA>@<9+S &
M&$ZER?^!]-,HP+$ !&:1?3'&LO $=:F'-Q90S(8@''R(?I7RX/!D)34F*+WX
MM]1$64D Y)9H<7XA61U/3L\GK^<N-,D4]%-I&>Z0Q90=,LPM/)8+7*Q4%?/Z
M(;>SA=K2IA6N8920 6&IE$X3\3[^MW3<RK5BT$T>N.^**OF3NUC#=X&UP!<V
MEI8;)69$I>R[:,'-%88V@UP@:-0\#-HE;R=DQ%STV4%XPF-A4L0B"4/K$3-W
M+/#E]A*7,+P""^$5GLC%Y]R !J#L@/Y-KE0)C2)"#,WQ0A9DF@)Y%9R=",Z#
M0/CS.YQC!>GV0HJ2Z'I@F]3>97/HX66BC=D+ND:@S@PNBIG<\;T\^779?/P8
MF\64<<T4/1P*#)*G_@[\;3(+\)X96.GL1(Z(#Z;;!+U$UI7'6E%N\O CW.0?
M' R:4]E(+6&SS!X @"4/I W7BF38+WSI2XT\5+\C<&\??!@OL/R0XQY00-[M
MPKA:>G J11!9!&&'V0)7G2*E:%#R_]V\;L3V[\@QC'/RWTO8Y!/&9>Y4<ED]
M'2C/)T^98*&+"5XO4CO.CC@/L%Z6F<F0Y/Y_.4>^WC;:(.K4FH"$8_I)G@8W
MT14.K90L<(?Y*V0#* 4HF><'Y@3SC.#_8^]9#&1()7R06W ?'TK#!:MD6>AB
M]X6,FC#G9;C<05F@5D;NC.AO3:WO@:IF8D(98B>L:$9Z'X)WF6.ILQHR&O#8
M YZ>AB &?%RP&O),^Q"BL##N$G8ZJY_KHX;_STNZ;MMSC^]I2\,%=(Q[ 49"
M75PIQ'U(C3!Z6XRGT-'M,F:'J*IXUL0TI@RS,%Z:;DQUH+PS/;<^!2]?I36C
M$.M"!;,03$$P>R=U[R)RC&%H3.<S=W&=1Y@M&]8R09-?-T%:@+$!4",2 #3!
M'Z8&H3DS"#):?"=WC=O9KG$M=XU/T:ZAPCX4(/3@373^,:4[EO8Y@RX<5BL:
M@>NB9*EW?C!7HNX#_+#UBZ6B\)T"5I1 ;D^?CP[#(>YEIJDHR4D5)"43*;W
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M;'XMD;R62%Y+)#\!1UY+)+\VJV538>MUH77+-U%$L-V#T=^M='0W'3P]Y*>
MA.HQ[1IM[6N=R<M$9_)V_032KRC@FSM^<Q[D]I5D52U+Y1]/9/[Q<GK7H3/+
M)8<%"^E+>-L]TRR3#F"3&8[7C_)Z,O'Q4UXVCYZC6/I(^9)KAQO(S9ZYGSS>
M_NA;[2='+X!63%9V><OPIWFKX,D/W<_+6=@Q-NT3'L#?)F/!5BC>GG7=0BT3
MOF3YV,7_%*V9W=A?7QR?\<4!C]"S<OP"2H%?=<2F?N:*%P/6H=^VGE?'1:Y\
M*I.2\*M/_:%>UO12L6AJ]VQ\<I+3\@-_F*WA$8*S JUM[]7US5'2IRCI$4IK
MR6,D#<^7PQ?AU!I<N94U[K8JH*FZ&OB/ZF8.F;N9<R /$9AD_LNH=L/6Y^C0
M8[RO/_OLU/1ZRXN<G0II+,U 7E7A%[];8#V3\'UV!*U8?HKIWZFJ[=Z&-P1,
M*ZN1H#= 295$/\>JKOR^C3T&&Z)IJFJQJLY\>MO^0$SU_6\[?Z=J-\6OQVNR
MI=>:[)9KLEL[>?)SG(B)?W=N\^JF?O='>ZO?U/LR9\]2(]K;N=-?+F@-=\/H
M>LW70 [27CPP VM"#!K(RB">5@M?#U>',S$E'>9/L>#790-J]:(LDGQ93W7
M\V&![8N,!$<#?R!<L);F;NYEON1#[QMDG=9'8&G8-_^BY>H$0A)U?,!(A8VF
M_&I4L"GS;EFX&^)>"#/B9O(F6XK9_:5?7MF-;SJ;(C673SC$%2:WZ91.&_5)
M3:K,3;>=M41NPW0+6/0]D!UO)]54XNO9]7:[;*W@%4C'QR^T)?4\Z>"Y8L,5
M^#K@L]>2@N_B)_@^5#5!W]KW1$>^US:'3V/ 60\L8/2M*BWYK2JN]+/#MEF*
M4K7%T=UFRO3[6JT5KE;YE+1D%L&KD@_XI1$_B.?U(F?37I 3/_:QY 2X0E>8
M$Y1_"(.MVO\#4$L#!!0    ( (F$EE@2Z;M'"Q$   ]%   6    =&TR-#$R
M,S P9#%?97@Y.2TQ+FAT;>U<;7/;-A+^KAG]!YQG+F//2;;DM$ECJYZ37^)H
MJL0^2_6UGVX@$I)P)@F6("6KO_Z>79 4;<E)U,J]M)-\B&,*!!:[S[ZOTGDW
M?-\_J=<Z[RZZY_@IZ$]GV!OV+TXZ!^XG/CW(/^Z<7IW_+ ;#G_L7W^^,390>
MB78K3L50A\J*#VHN;DPHHX9[T! #E>CQ#E[$J]?%>Z%,)CHZ$JV=DQ?1R,;'
MG8/K1TM2=9\V9: G6);HR30]%I6W.J<G%_=3/=*I>/-FO]TY.#U9W:)<?RRJ
MNP5JG/(.G=[[2S&X.<-AX>$W[<.7K9;?_H^Z?_.FV=;AI-5J[_\WGNR(;G_X
M_<Z2T@V.8L)WUJS_7,95+HVECW;W5)2JA*_R,=JV?=9PBM4S^2)-I*^.Q:DV
M@9EHSXK4B.M$6:RDGUZ@(^W)H%X[EZD4@RR.39+J:"+2J1+7)L4Z+0,Q6$0J
MF2R$&8O;LP_-5EO(R!=O=6+39E]'6"HC+U$RU9XXPS]5(LZF*C38)9'Q0MRH
M"2X162%3WKD;@CQ/1F)@/*W2A1@;O*$"$$(;7RIL.<S?/7S=&?QX?9)..P?T
M4W2C* -)[Y5B0I^1G__-;*K'BS]8>#V<Y4L[/1:=MU<?AM5#FE;_JMQ).R=]
M)?UZ+4Z,GWFI #-][<M4-0H)Z4AX)ASI"%(QD9CK="H"'1L+P@*A$QU!O"0#
M'X**+)"2*E^H:$KR\R'@5#?3+(1@U'BLO-32CE),,]Q+Q$MYAR:SJEZ[5Y&9
M)'*<=@Z([.(2G8/><W/L*>OT7&(!,(49697,P":;:X8*XZDD\=B<_R\2^TMF
MCBU$5*H1&.CKF4JL$EY5/2IRLJP*.H1<:7NP'GKB+>A54IR4F!Z2]D(5*T+P
M6.G^M#QG%;LQWMU,!P$@_/Z\(;IQH@-Q>-@0AZW#;T1YM],3\91UJ]=V/_P\
MN"C-RY$87MW^M-< ;!W?]5B#J875:]I43A1Q'YQ<0 ]F*C!Q;OT@&)6E9#)]
M97%WO ?;R?S/N<TV,%$!ZXVOK9)6D9+ AF&5)0E-X5M$%H4J%9%2?@-;^'*!
M%R.3L9:13&-GCYV:DEB7=EGX9):7"DJT?4)#'^MGO9936RIH<Z1D0CN%VLL1
MA=V<?8!-$2LFI6KSUUF0?1((,,W$6N=#W,U*Y.=J4J\]]"!C]B !>9 5,#]4
MD23W( U^;PZ8B)$28[R0):">31,H S@?\O,)AU.O%1Y'K#B<W>[@\FRX]PG'
MT\#YQ,2I"GPQ IUBII,4"X(%;PF*3F60:H@'="8F%.\A^=?-=ML!>O^YG=;6
M5?1%X)-%(_/'DBZ9G_,XBZ%)Q!+FGPAS!SW*-#@$40#6$ LXKX&K:()89(HW
M;3:9*.MVJ/JKAT!)36PT< <) 6@]<)<#2Y. 6IMY4P%]6P?-!BZQ($3/M*\
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M+A<VAY0ZVFJ _5R!^\[)%11QIM7\B(/!]:KVCQ6CM4L/VGM5XU6O?=QZ01F
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MK,YY[_9A9\FI6/MPC8Z]HF<CD_@J*9^=!M*[$VT08!'\^"!@M5-%JKD44N<
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M+3(P,C0P-#(R7VQA8BYX;6Q02P$"% ,4    " ")A)984V/(K5T'  #H5P
M%               @ &*#@  <WEN+3(P,C0P-#(R7W!R92YX;6Q02P$"% ,4
M    " ")A)98QQL_>1H7  !QC@  $@              @ $9%@  =&TR-#$R
M,S P9#%?.&LN:'1M4$L! A0#%     @ B8266!+INT<+$0  #T4  !8
M         ( !8RT  '1M,C0Q,C,P,&0Q7V5X.3DM,2YH=&U02P$"% ,4
M" ")A)98#2P 4&4'  #2%@  %@              @ &B/@  =&TR-#$R,S P
C9#%?97@Y.2TR+FAT;5!+!08     !@ & (H!   [1@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>tm2412300d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="syn-20240422.xsd" xlink:type="simple"/>
    <context id="AsOf2024-04-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000894158</identifier>
        </entity>
        <period>
            <startDate>2024-04-22</startDate>
            <endDate>2024-04-22</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-04-22" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-04-22" id="Fact000004">0000894158</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-04-22" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-04-22" id="Fact000010">2024-04-22</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-04-22" id="Fact000011">THERIVA BIOLOGICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-04-22" id="Fact000012">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-04-22" id="Fact000013">001-12584</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-04-22" id="Fact000014">13-3808303</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-04-22" id="Fact000015">9605 Medical Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-04-22" id="Fact000016">Suite 270</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-04-22" id="Fact000017">Rockville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-04-22" id="Fact000018">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-04-22" id="Fact000019">20850</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-04-22" id="Fact000020">301</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-04-22" id="Fact000021">417-4364</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-04-22" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-04-22" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-04-22" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-04-22" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-04-22" id="Fact000026">Common stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-04-22" id="Fact000027">TOVX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-04-22" id="Fact000028">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-04-22" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
